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Research has shown that patients in the first two stages
of HIV disease experience significantly higher levels of
depression, mood disturbances and anxiety than do those
patients with AIDS (Wadland & Gleeson, 1991). As a result of
the Concorde Study, treatment for patients in these stages
has changed to a more negotiable process often bringing
health monitoring rather than active treatment. Survival in
this stage of the HIV continuum will depend more on coping
skills than on medical interventions.
This experimental study (N=l9) examined the effectiveness
of a six week biopsychosocial program "Living with HIV" as an
intervention to decrease emotional distress, and increase
personal control and medical compliance. Scales to assess
emotional distress included: Beck Depression Inventory,
Hamilton Depression Scale, Hamilton Anxiety Scale, Impact of
Event Scale and Multidimensional Health Locus of Control,
Form C. A Medical Review Log assessed appointment compliance
for three months following the program.
The quantitative findings combined with the participants
subjective responses and actions to the study provided
findings of clinical significance. The stress inoculation
model of "preparation" was bidirectional in its application
between those living with HIV, and those providing their
medical and mental health care.
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DEDICATION
This research effort is dedicated to the individuals who are
courageously living with AIDS, and to those who have died
from AIDS.

CHAPTER I
DEFINING THE TOPIC OF THE STUDY

"The challenge of HIV infections to society in
general and health care professionals in
particular represents the most dramatic and
threatening public health problem of the decade,
if not the century" (Cohen, 1990, p. 98).

INTRODUCTION

Having the Human Immunodeficiency Virus (HIV)
major, stressful life event.

is a

It forces people to deal with

many painful and difficult issues such as declining health
with its attendant multiple losses, discrimination, and
prejudice.

The emotional distress that comes with living

with HIV and its medical uncertainty is compounded by that
of disclosing the diagnosis and one's risk factor to family
members and employers.

This action threatens or destroys

one's supportive relationships from a personal, family,
social, and employment perspective.

The patient's battle

for survival is dependent on the scientific and medical
management of the virus and sustaining hope while combating
the stresses of living daily with HIV.

We are now into the

second decade of extensive scientific research and clinical
trials, but are still without a cure for the deadly virus
that causes Acquired Immune Deficiency Syndrome (AIDS) .
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Progress has been seen in the medical management of HIV
through the timely use of prophylactic treatments to delay
the onset of infections that further destroy the immune
system.

This focus on early intervention is a means to

prolong life and delay the onset of AIDS through the
appropriate use of antiretroviral drugs.

Zidovudine (AZT)

remains the most commonly used antiretroviral agent for
treatment and is considered the first line of defense
against this disease (Lipsky, 1994).

The efficacy on the

timely use of this drug has now been challenged.
In light of the recent published data from the Concorde
Study, the antiretroviral drug AZT has been shown to have
limited effectiveness in terms of disease progression and
survival in early HIV disease (Aboulker & Swart, 1993).

In

response, a panel of experts was convened by the National
Institute of Allergy and Infectious Disease which
recommended that medical intervention in the earlier stages
must now focus on education and counseling.

Decisions as to

when to start medical therapy must become negotiable,
creating a shift away from a paternalistic approach in
medicine towards a doctor and patient partnership in medical
decision making.

These changes will add more uncertainty

and an increasing level of stress for those living with HIV
and those providing care.
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STATEMENT OF THE RESEARCH PROBLEM

With the major disruptions in the medical management of
early HIV and the changes in treatment approach the
possibility now exists that HIV-infected people in the early
stage of the illness could experience a latency period in
medical treatment, receiving health monitoring and
counseling instead of active therapy.

Survival in this

stage of the HIV continuum will depend more on coping skills
than on medical intervention.

Research has shown that

patients in the first two stages of HIV disease experience
significantly higher levels of depression, mood disturbance
and anxiety than do those patients with AIDS (Wadland &
Gleeson, 1991).

These disturbances, and a sense of

helplessness and hopelessness, may be exacerbated by their
need to rely on medical technology and a paternalistic
approach to medical care.

PURPOSE OF THE STUDY
The purpose of this study was to examine the
effectiveness of a biopsychosocial educational program in
the pre-AIDS stage of the illness.

This research project

studied the efficacy of this model as a prophylactic
intervention for decreasing stress that leads to depression
and anxiety, while increasing the individual's health locus
of control and medical compliance.

This study was designed
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from a cognitive-behavioral perspective utilizing the stress
inoculation model to enhance coping, adaptability, and
survival by creating hope, while at the same time helping
people prepare for an illness defined by its uncertainty and
unpredictability.

This is a program of "preparation" that

is contextual to the needs of HIV-infected patients and
their loved ones as they proceed in their personal evolution
and journey along the disease continuum to its final stage.

RATIONALE
In the current climate of health care reform and cost
reductions, another layer of stress due to limitations of
medical therapy is now being felt by people living with the
HIV virus.

This creates a significant need in this patient

population for increased consumer education and mental
health counseling that will promote a sense of control and
empowerment in the earlier stages of this disease.

The need

exists for relevant and timely therapeutic methods for
adaptive coping that seek to create synergy with the
changing medical management for HIV in the early stages.

A

biopsychosocial perspective for mental health intervention
serves as a "stress inoculation'' against the emotional
despair of being HIV infected.

Since the stigma and fear of

AIDS continues to be felt in society by those infected and
those that care about them an increasing need exists for
medical, social, economic, and legal resources.
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DEFINITION OF TERMS

For the purpose of this study, the following key terms
were defined.
HIV-INFECTED PERSON: An adult who has tested positive

on the Enzyme-linked Immunosorbent Assay (Elisa) antibody
and confirmed by the Western Blot test for HIV virus that
causes AIDS.
DEPRESSION: Mood disturbance described as sadness,

despair and discouragement. Symptoms may include feelings of
helplessness and hopelessness with complaints of sleep
disturbance, loss of appetite, fears of abandonment and
death, along with a high risk for suicide. A range in levels
of depression is universally experienced by HIV-infected
individuals from a reactive to a clinical to an organic
depression in the life-time of the disease.
ANXIETY: Apprehension, tension, and fears universally

experienced by HIV-infected people when the stress and
threat of a catastrophic illness overwhelms their capacity
to cope.

The presentation of physical and verbal

expressions of anxiety begins with their diagnosis and
continues at various levels throughout the illness around
issues of disclosure of diagnosis, changes in symptoms and
in their CD4

(T-lymphocyte cells) counts threatening the

ability to cope.
MEDICAL COMPLIANCE: The extent to which a patient is
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compliant to recommended medical advice by keeping scheduled
clinic appointments.

Information regarding compliance with

clinic appointments was charted in the progress notes in the
patients' medical chart.
BIOPSYCHOSOCIAL EDUCATIONAL PROGRAM: A six week

educational program designed from a medical model developed
in a general systems conceptual framework to meet the
patients' multidimensional needs from a biological,
psychological, and social perspective.

Each of these needs

is given equal weight in clinical formulations from an
interdisciplinary perspective in developing the program.
STRESS INOCULATION MODEL: A cognitive-behavioral

educational-skills-training approach of enabling behaviors
as a "preparation" to empower people to cope with impending
threatening events rather than being disorganized by anxiety
or inappropriate actions as a result of denial of real
dangers.
HEALTH LOCUS OF CONTROL: The extent to which

individuals believe their behaviors result in the ability to
exercise some control over their health situation.

And they

recognize their internal influence on their health as well
as the influence of powerful others on health care decisions
and outcomes.
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RESEARCH HYPOTHESES

This study examined four research hypotheses.

The

method for addressing their statistical significance is
stated in Chapter III.

The research findings are found in

Chapter IV.
Hypothesis 1:

Participation in a biopsychosocial

educational program will result in a decrease in
anxiety in the experimental group compared to the
control group.
Hypothesis 2:

Participation in a biopsychosocial

educational program will result in a decrease in
the mood disturbance of depression in the
experimental group compared to the control group.
Hypothesis 3:

The experimental group will show

increased levels of locus of internal control
versus physicians' and significant others' control
as a result of their participation in the
biopsychosocial educational program in comparison
to the control group.
Hypothesis 4:

Participation in a biopsychosocial

educational program will result in a higher level
of medical compliance among the experimental group
versus the control group for a period of three
months following the completion of the program.
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SIGNIFICANCE FOR CLINICAL SOCIAL WORK

The dynamic interplay among the multidimensional needs
of the HIV-infected person challenges Social Workers
schooled in the biopsychosocial approach to promote survival
through education and change.

A vital need exists for

Social Work leadership to develop multidisciplinary
approaches for balancing the medical and psychosocial
context of the disease with the internal and external
strengths, resources, and supports that enhance coping and
survival for HIV infected people.

This holistic approach

would create a triad of interactions between the person, the
illness, and the environment.
Working with this at risk population epitomizes the
view of the social work profession as a contemporary
practice that is contextual, interactive and multimethod in
orientation and characterized by the person-in-situation/
person-in-environment interface (Saari, 1986).

This

psychoeducational program will help HIV-infected people to
develop coping strategies that promote self-worth,
self-esteem and options to "live with" rather than "die
from" HIV/AIDS.

This research effort speaks to the inherent

social work values.

And these values in purpose and method

have an ethical responsibility to honor, to preserve, and to
facilitate the patient's self-determination (Levy, 1983).
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ASSUMPTIONS OF THE STUDY

This study was predicated on the assumption that the
organizing content of the biopsychosocial educational
program "Living with HIV" is a useful modality for HIV
infected adults in the pre-AIDS stage of disease that merits
attention.

It was assumed, based on the literature and

clinical observations, that the stressful situations
impinging on this population lead to anxiety and depression.
It was further assumed that cognitive-behavioral methods for
addressing these stressful situations could result in
strategies to increase coping abilities and decrease
emotional distress.
The medical setting represents the major resource for
the HIV-infected population.

This study then assumed that

the study methods and site would prove highly relevant for
their needs.

Further it assumed that graded exposure to the

medical and psychosocial aspects of this disease is most
appropriate for this setting, and that the interactions with
their medical care team will provide a model for the present
and future needs.
Finally, it was assumed that a program based on the
stress inoculation model of preparation in the earlier
stages has sustaining capabilities as the disease
progresses.
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SUMMARY

AIDS, and its manifestations of the HIV infection is a
paradigm of a medical illness in crisis.

Changes in the

early medical management of the HIV disease creates a
challenge for an equal focus on the psychosocial management
of the disease for those who are HIV-affected.

One approach

is a biopsychosocial educational program utilizing the
stress inoculation model to create synergy between the
changing medical care and the psychological, social, and
environmental affront to patients' existence.

This

structured program is designed to provide opportunities to
create equilibrium between the crisis reaction to being
HIV-infected and the capacity for enhancing coping
strategies to live daily with this disease.

CHAPTER II
REVIEW OF THE LITERATURE

In response to a paradigm in crisis, Kuhn (1970)
states "let us then assume that crises are a
necessary precondition for the emergence of novel
theories and ask next how scientists respond to
their existence" (p. 77) .

INTRODUCTION

The Human Immunodeficiency Virus (HIV) , with its
manifestations that lead to Acquired Immune Deficiency
Syndrome (AIDS) , is a paradigm of a medical illness in
crisis.

Now after more than a decade of extensive research

and clinical trials in a consistent effort to unravel the
secrets of the HIV virus, the scientific world is still far
from developing therapy to abate its advancement, let alone
find a cure.

In fact, a recent study revealed that the one

drug that the medical community put all its hopes on, AZT,
proved less effective over time in prolonging life and
delaying the onset of AIDS than first anticipated.

This

unwelcome reality in the medical care of HIV-infected people
creates a shift in the decision making process away from the
dependency on medical technology and towards the creation of
a partnership in care.

It is now possible that infected
11
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people in the earlier stage of the disease will depend more
on coping skills than on medical intervention.
In the 1980's when AIDS was first diagnosed, the fever
pitch for scientific intervention left hope for both control
and cure of this deadly disease.

Behavioral research at

that time focused intensively on risk reduction change
processes and, to a lesser extent, on the mental health
needs of persons infected with HIV disease (Kelly & Murphy,
1992).

The need now exists for research models of

intervention that facilitate the psychological well-being of
HIV-infected people, a cognitive-behavioral focus that will
empower, sustain, and engage them in their health care in
the earlier stage of the disease.
The following literature review was organized to be
used in two ways: as a resource to support the clinical
significance of the study, and as a tool in the therapeutic
framework for intervention.

The literature review includes:

a) stages of HIV disease; b) impact of the earlier stages of
disease; and c) theoretical framework for intervention.
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STAGES OF THE HIV-DISEASE
AIDS is a life-threatening illness caused by the HIV
virus that severely attacks and weakens a portion of the
immune system.

When the damage is severe, the body is left

unable to fight off certain infections and cancers that
healthy immune systems destroy with ease.

The virus spreads

by specific behaviors that directly expose one person's
bloodstream to the infected body fluids of another, such as
blood, semen, or vaginal fluid.

The Center for Disease

Control (CDC) reports that 17 million people in the world
are infected with the HIV virus.

The total number of

infected persons in the United States is currently estimated
at one million or about 1 in 250 persons.

Those diagnosed

with AIDS by the end of 1994 will be between 415,000535,000, and the number of deaths to date along with
projected deaths by the end of 1994 will be 312,000-385,000
(CDC, 1994).

Statistics continue to draw our awareness to

the devastation of this disease and the concomitant
limitations of medical interventions.

The HIV/AIDS virus is

now the leading cause of death among American adult males
ages 25-44

(CDC, 1995).

Exposure to HIV is greatest among a population engaging
in high risk sexual and/or drug abuse behaviors.

The

majority of people infected with the virus in the United
States are homosexual and bisexual men at 49%.

A decline

continues in this population due in large part to a well
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orchestrated educational effort in the gay community.

The

areas of increase are among intravenous drug users (IVDU) at
33%, and women, due to both intravenous drug use and
heterosexual contacts at 17% (CDC, 1995).

Today, the most

rapidly growing populations infected with HIV are women and
teens.

And with the growing number of women infected with

HIV, health care providers are witnessing a rising number of
newborn children also infected.

AIDS is now the leading

cause of death for young women between 21-35 years old in
four major cities in the United States (CDC, 1994) .
The first medical model of AIDS was that of a disease
with an acute onset and a prognosis of two years or less.
Prolonging life is now possible due to scientific advances
in the identification of biological markers and antiviral
therapies that slow down or control some infections.

This

has resulted in a reconceptualization of the HIV virus as a
chronic illness (Grohman & MacDonell, 1992).

The clinical

view of the HIV virus is that of stages on a continuum from
seropositive asymptomatic status to AIDS, the final stage.
Although disease progression varies widely among individuals
(Hamburg & Fauci, 1989) the three stages of illness
typically will unfold between nine to twelve years from
infection to AIDS:
Stage 1) . an asymptomatic period of more than four
years average duration.
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Stage 2) . symptomatic with AIDS-related complex for
about five years.

Stage 3). AIDS characterized by various opportunistic
infections, i.e., HIV wasting, HIV dementia, lymphomas,
and CMV retinitis on an average of nine to 12 months
for treated and untreated individuals combined, and 21
months for those receiving antiretroviral treatment
(Lemp, et al., 1990).

It now appears that the diagnosis of AIDS will develop in
most, if not all, HIV-infected individuals (Grohman &
MacDonell, 1992).
The utility of a staging system explicitly imposes both
a structure on the natural history of the disease and
provides clinical markers for intervention (Royce, et al.,
1991) .

Souri (1991) uses the stages as a schematic that

provides his patients with both a basic knowledge of the
disease and progression while also providing a realistic
assessment of life expectancy.

He does not indicate

however, what other counseling sources he utilizes prior to
and after this frank discussion.
Along with stages comes the biological markers of CD4
{T-lymphocyte cells) counts, the direct measure of the
immunologic status that dictates treatment decisions (CDC,
1992) .

For this reason, CD4 counts are closely monitored
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not only by the physician but the patient as well.

The rise

and fall of these counts due to multiple variables often
results in general emotional distress, mood disturbance and
anxiety for patients and their loved ones.

The normal range

for CD4 counts is 1000 with a plus or minus of 500
lymphocyte cells.

An expanded classification system of

stages includes corresponding CD4 counts and illustrates
when medical interventions are indicated:

Stage 1./Category 1:

Stage 2./Category 2:

Stage 3./Category 3:

~(greater

than) 500 T-cells

(between) 201-499 T-cells

~(less

than) 200 T-cells (MMWR,

1992) .

Inherent with this classification system is the
knowledge that infected people enter medical settings at
various points on this continuum.

This demands a

bio-psychosocial assessment of the patient with
interventions that are stage appropriate from the medical,
psychological and psychosocial perspectives.
The paradigm of the AIDS illness that dictated medical
management of early HIV infection has changed since the
publication of the Concorde Study at the Ninth and Tenth
International Conference on AIDS in 1993 and 1994,
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respectively.

This three year randomized, double-blind,

placebo-controlled study found no significant benefits, in
terms of either survival or disease progression, of early as
opposed to delayed use of AZT, irrespective of the CD4 count

(Aboulker & Swart, 1993; Lipsky, 1994).

Before the report,

newly infected people were typically started on AZT when
their CD4 count was 500 or greater.
In response to the study, a panel of experts convened
by the National Institute of Allergy and Infectious Disease
offered several modifications of this and other aspects of
treatment.

First, they argued that in the absence of any

clear advantage to early initiation of AZT, the decision of
when to initiate AZT should become more of a negotiated
process between the physician and the patient (Glick, 1993)
Second, they strongly encouraged more education and
counseling in the earlier stages of the illness.

Third,

they stressed the importance of creating a partnership in
treatment decisions not only in early but also in advanced
stage of the illness (Glick, 1993).

Summarizing the new

directions, Glick (1993) felt "the choice to accept or
decline antiretroviral therapy will rest ultimately with the
patient (p. 6).
In many clinical settings these recommendations
represent a major departure in medical practice for both the
physician and the patient.

To execute them would entail a

cognitive reframing in decision making from the patients'
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dependency on technology to a collaborative process that
involves more control, that is more empowering for the
patients.

It is possible that HIV-infected people in the

earlier stages of the illness will experience a latency
period in medical intervention, instead of active medical
therapy they will undergo health monitoring and counseling.
In fact,

in the overall sequence of stages through which

they will live and cope with this fatal disease, patients
will spend the greatest amount of time in these early
stages.

IMPACT OF HIV DISEASE IN THE EARLIER STAGES

Testing positive for HIV is a major stressful life
event with feelings ranging from a period of shock and
numbness, to excessive intrusive thoughts (Cohen, 1990;
Ferrando, 1992; Wadland & Gleeson, 1991).

Hearing that one

has a disease without a cure, with limited available
therapies, high elements of uncertainty, and a
stigmatization from a society intolerant due to the route of
transmission, is a crisis.

Living with the stress of this

chronic illness is compounded by living with the daily
stresses of the 90's and the pervasive feelings of
insecurity.

The reality of being HIV infected brings fears

of infecting others, telling others, and losing the love and
support of others.

The crisis in this early stage, as
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Wadland and Gleeson (1991) have observed, is expressed in
symptoms of depression such as helplessness, hopelessness
and worthlessness.
Being out of control is one of the most common basic
fears.

The crisis in learning that one has the HIV virus

ignites this basic fear and often results in behaviors in
search of control.

Upon receiving the positive test results

many people will challenge the validity of the test and the
laboratory's credibility with demands to be retested.

The

resulting reenactment of the waiting period produces
incredible stress and anxiety only to hear the confirmation
that changes their lives forever.
The cognitive theory of stress and coping (Lazarus &
Folkman, 1984) is centered on the ability to appraise
personal control in a given event for stress reduction and
adaptive coping.

The reality testing of one's appraisal

creates a balance between problem-focused and emotionalfocused coping.

However, situations of uncertainty and

ambiguity prevent the necessary cues from which to make
these determinations.

An ensuing imbalance of emotional-

focused coping occurs and a defense such as denial
dominates.
Upon learning of his positive test during a routine
physical exam a 27 year old man who claims a monogamous
relationship for seven years, refused to accept the
results.

This was further reinforced when his partner
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tested negative.

He proceeded to be retested in four

different medical settings.

To his despair, they were

all positive, and he was in the late stage of the
disease.

And his denial continued.

As his counts

declined and his disease progressed he still refused to
take any antiretroviral therapy.
Traditionally, denial has been viewed as a maladaptive
defense that interferes with our perception of reality, a
hallmark of mental health.

Denial, however, is an important

coping defense for many HIV-infected people, for it allows
them to continue to live "as if 11 the disease was not fatal,
a workable strategy today given the limits of the scientific
achievements against the HIV virus.

Lazarus (1985) in his

review of the cost and benefits of denial speaks of a
"partial" denial that involves the capacity to bring the
denied reality into awareness when necessary.

An example of

this is the reality of being at risk for HIV and being
tested.

The cost side of this denial is evident in the

failure to return for results and avoidance of symptoms
only to be suddenly admitted to a hospital with a
progressive life-threatening illness.

A crisis ensues for

the patient and loved ones who were unaware and unprepared.
In our western society, personality is often predicated
upon a powerful denial of finitude.

Denial allows us to

plan for the future, raise children and develop careers and
contribute to society.

Being HIV infected pierces that
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important denial and leaves many individuals vulnerable to
extreme existential anxiety.

But it is also the process of

denial that provides the individual the proper pacing in the
revision and rebuilding of one's basic theories and
assumptions of life (Janoff-Bulman & Timko, 1987) .

This

important defense, when balanced in the context of the
stress and coping theory, provides temporal transitions and
the cognitive reframing from fear to hope.
The ability to prolong life through timely
interventions has changed HIV from an acute to a chronic
illness.

Among the factors that enable patients to cope

with a chronic illness is their belief in the ability to
control their own health.

A study examining feelings of

control and adjustment to physical illness was conducted
among patient's with cardiac disease, cancer and AIDS.

The

results found that belief in personal control is generally
adaptive and appears to reduce anxiety. However, patients
that tended to profit psychologically from a sense of
personal control were patients with a good prognosis, as
opposed to those with a poor prognosis (Taylor, Helgeson,
Reed, & Skokan, 1991) .
Folkman (1984) theorized that the generalized beliefs
about personal control that individuals assume over
important outcomes is a major influence in their cognitive
appraisals of an event.

Rotter (1975) formulated these

beliefs into the internal-external locus of control studies.
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Here events are contingent on the actions of one's own
behavior as internal control, and the actions of powerful
others as external control.

Wallston and colleagues (1978)

developed the Multidimensional Health Locus of Control Scale
based on Rotter's formulation with an interest in beliefs of
personal control over one's health situation.

These scales

have been recently expanded (Wallston et al., in press) that
further splits powerful others between physicians and
significant others.

This dichotomy is a repeating theme on

the HIV continuum between the patient's desire for control
and use of alternative methods compared to physician
control.

Differences often result in issues of compliance

and noncompliance with the medical management of this
illness.
Research conducted on the three clinical stages of HIV
disease shows that patients in the first two stages
experience significantly higher levels of depression, mood
disturbance and anxiety than do those patients with AIDS
(Wadland & Gleeson, 1991) .

This has important clinical

implications since there are indications to suggest that
people with AIDS would experience greater psychological
disturbance given a shorter life-expectancy and increasing
medical complications.

Linn et al.

(1993) in his study of

depression and anxiety in adults infected with HIV
hypothesized that people with more advanced HIV-related
illness would experience higher levels of depression and
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anxiety.

This community based study (N=156) used self

reporting scales that involved the Center for
Epidemiological Studies Depression Scale, Anxiety Scale and
the Perceived Coherence Scale with a predominately educated
young male sample.
Study results indicated that the stage of HIV illness
does not influence the respondents' sense of meaning and
purpose, or their depression or anxiety.

However, measures

used to determine the stage of illness were based on
reported symptoms over a 30 day period of time, and not
interfaced with the CD4 counts, the accepted staging
criteria.

The study also found that regardless of the stage

of illness, the degree to which patients derived meaning and
purpose was a significant predictor of their level of
depression and anxiety.
In another study, as part of a military universal
screening for HIV, 422 men were diagnosed seropositive. They
were further assessed for symptoms of anxiety and
depression.

Using both the Hamilton Anxiety Scale and

Hamilton Depression Scale, 84.4% had the presence of
anxiety and depression in the earliest stages of the
illness (Brown, et al., 1992).
The relationship between stressful situations and
psychological distress is commonly observed in patients
suffering from a chronic illness (Cella, Mahon & Donovan,
1990; Folkman, 1993).

The chronicity of HIV has a course
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that will wax and wane over several years.

The stressful

impact of this illness is felt with the rise and fall of the
individual's CD4 counts indicating disease activity.

A

study to measure the impact of disease recurrence was
conducted on cancer patients who had been cancer free for at
least six months and who experienced a recurrence.
Instruments utilized in this study were the Impact of Event
Scale and the Psychosocial Adjustment to Illness Scale given
to forty eligible participants with a mean age of 60 years
old.

A significant stress response was evident on the

Intrusion and Avoidance subscale of the IES.

The mean

Intrusion score was 18.0 (SD= 7.5) and the mean Avoidance
score was 24.6 (SD=8.0).

The researchers felt the results

indicated these patients demonstrated as much stress-related
symptomatology as people who present with trauma-induced
stress disorders (Cella, Mahon & Donovan, 1990) .

ANXIETY
The severe psychological stress associated with HIV
infection also contributes to a greater prevalence of
adjustment reactions with depressed or anxious mood than in
the general population (Levine, et al., 1991).

The

experience of anxiety is universal at some point in
asymptomatic or symptomatic HIV or AIDS individuals.
However, about 30-50% of this population go on to meet
DSM-III-R criteria for anxiety related disorders (Ferrando,
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1992) .

Anxiety for HIV-infected people is expressed in

themes of danger or harm to themselves or to significant
others, from the severity of panic attacks to the subtleness
of inquiry.

Differentiating what are unrealistic or

excessive worries about bodily functions is made more
difficult with HIV as it often presents with vague and
diffuse symptoms.
A dynamic often seen with HIV-infected people is the
cycle of vigilance "when I'm healthy I look for sickness"
versus "when I'm sick I look for wellness."

The anxiety of

waiting for "something to happen" is expressed often among
patients in the earlier stages.

One patient was so

overwhelmed with anxiety upon learning his diagnosis that he
took to daily body scanning and examinations.

He kept a

flashlight in his bathroom to check inside his mouth and
other areas of the body for any sign of change.

He would

also put on gloves upon entering his apartment and kept them
on to protect him from any infections from his pet cat.
The anxiety heard in those who are well is also heard
in those who are sick, creating another waiting cycle.
Another patient whose progression of disease had become more
complicated defined his vigilance in the following way:
"when I was sick before I had HIV there was always that
moment when you knew you were getting better.

You

could feel yourself getting over the hump - now I look
for that hump each day".
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Another anxiety provoking experience for those newly
diagnosed is the fear of losing control over one's thought
processes.

They often complain that they are "not on top of

things", a way of indirectly asking if they are mentally in
control.

For the well-informed, the fear of developing AIDS

Dementia often leads to HIV Anxiety with symptoms that
produce impairment in concentration and memory (Perry,
1990).

Many of those who are themselves infected are also
living with HIV-related stresses that include the illness of
partners, spouses, or family members.

A major concern in

this population is the repeated exposure to the trauma of
death as caregivers and powers-of-attorneys producing
features of post-traumatic stress disorder.

This is often

expressed in dream recollections and confusion between
symptoms of others and their own, along with intrusive
thoughts in the form of flashbacks.

Anxiety and the

overwhelming fears about general well-being and the loss of
control are also heard in the discontinuity of "feeling
well" yet having a disease that is life-threatening.

It

creates a sense of urgency and panic over what to do first.
"Who can I tell, not who should I tell," now occupies and
worries the infected person's thought processes.
Clinical experience with HIV infected people in the
first stage finds that, due to emotional distress, many
begin to prematurely plan and prepare for death due to their
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feelings of helplessness and hopelessness.

They tend to

withdraw in their work focus or professional career goals.
This can often lead to poor judgment and premature
disclosure at work that threatens the loss of job, identity,
income, benefits, and a quality of life.

This phenomenon is

often referred to as the Magic Johnson Syndrome.
The degree of generalized anxiety in this population
will vary according to personality, culture, coping styles
and stage of illness.

Its outgrowth is the result of

adjustment reactions to being HIV infected.

Those

struggling for control tend to overwhelm themselves with
massive educational materials and alternative treatments.
They are determined to be that first person who will "beat''
this disease. Others with dependency issues experience
overwhelming feelings of helplessness and endure greater
adaptive problems in asserting their rights and
entitlements.

And still others will act out their fears

with high risk and self-destructive behaviors such as unsafe
sexual contacts, alcohol and drug abuse.

DEPRESSION
Depression is another universal reaction to a
life-threatening illness that ranges from reactive to
clinical and organic, of which an estimated 20-60% meet the
DSM-III-R criteria for major depressions some time in their
illness (Ferrando, 1992) .

Inherent with this disease that
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causes immunosuppression is the dual effect on the central
nervous system.

Perry (1990) has found in his clinical

practice that HIV-infected adults experience a subjective
sense of mental slowing, forgetfulness, apathy, lethargy,
social withdrawal, avoidance of complex tasks and
personality change before the development of AIDS.

A major

difficulty for clinicians is distinguishing depression from
the physical and/or organic symptoms from the HIV disease.
Beck (1985) saw three major negative patterns triggered
by depression in the individual: a negative view of self; a
negative view of experiences and the world; and the loss of
an expected future.

This triad of cognitive patterns is

clinically expressed by HIV-infected individuals who
describe feeling defective and separate from the rest of
society. ·Individuals attach a prevailing sense of shame and
worthlessness to their diagnosis that is overwhelming and
dysfunctional.

The negative experiences of rejection and

abandonment are recurring themes as the disease unfolds,
leaving a view of the future filled with unsurmountable
obstacles.

And finally, the remeasured life span of those

infected with HIV creates an irreversible alteration in
their future with the process of saying goodbye and
preparing for death.
For homosexual and bisexual men the comorbidity between
emotional distress and HIV has been established (Cohen,
1990; Ferrando, 1992; Levine et al., 1991; Perry et al.,
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1990).

This factor further impacts on the psychological

distress of being a member of a minority sexual culture.
Perry (1990) found a 50% lifetime prevalence for depression
in two major risk groups, homosexual and IVDU populations,
prior to testing.

It was felt that the emotional distress

of being in this minority culture would result in higher
scores on distress scales regardless of the HIV diagnosis
(Britton, Zorski & Hobfall, 1993).

Symptoms such as

insomnia, low energy and motivation, decreased appetite,
decreased libido, guilt, suicidal ideation and decreased
concentration overlap with commonly seen symptoms in HIV.
Depression tends to become chronic after the initial
"adjustment reaction,'' especially in patients with a prior
history of depression.
For gay men diagnosed with HIV the fears of disclosure
dominate the fears of the disease.

A major clinical issue

with this population is the timing of the diagnosis with the
coming out process.

How the patients cognitively structure

the event is related to their underlying beliefs, attitudes
and assumptions about themselves (Beck, 1985).
according to Cohen and Abramowitz (1990)

Having HIV

"may stir up

self-blame, self-hatred, and internalized homophobia in
certain gay or bisexual men"

(p. 163).

Along with these

feelings are the issues of guilt and shame.

Stone (1992)

re-examined the role of shame in the post-traumatic stress
disorder. He saw the affects of shame and guilt as
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coassembled with fear, specifically the fear of punishment
for a wrongful act.
Being HIV threatens the secretive lifestyle for many
gay men unknown to family, employers and even neighbors,
resulting in withdrawal.

Anxiety and depression surround

the dilemma of who to tell, when and how.

Fierson (1987)

found that communication was most strained between
homosexual men with AIDS and their fathers, and least
difficult between siblings.

The art of maintaining secrets,

not giving them up, has been a surviving technique in this
culture.

But as one gay infected man explained to his

partner "being HIV is like being pregnant, it will soon have
to come out".
Survivors' guilt is another dynamic that leads to
depressive symptoms in this population.

The mere fact of

surviving, of existing, when your partner has died creates
distress.

Given modern medical advances, death among young

people has long since ceased to be normal - but not for gay
men.

Clinics and physician off ices continue to see many of

the partners and friends of the earliest AIDS casualties
whose role as caregivers brings "experience-near"
familiarity with HIV.

They often speak of these experiences

as a mirror reflection of their own destiny.

This

population has had to endure massive losses with unresolved
grief making death less an individual event, and more an
environmental event (Sullivan, 1990).

With the loss of so
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many friends, patients' resources for support and care are
limited, if not exhausted.
Newly diagnosed people whose risk factor was (and, for
many, continues to be) intravenous drug use (IVDU) bring a
history of depression and maladaptive coping to their new
medical crisis.

Perry (1990) found this major risk group

had a 50% lifetime prevalence for depression prior to
testing for HIV.

Cohen (1990) postulated that

psychopathology has a major role in the initiation, onset
and course of AIDS in this population.

Khantzian (cited in

Cohen, 1990) has proposed that IV drug users are depressed
individuals who seek drugs to medicate their depression.
The affective disorders associated with buying, selling, and
using drugs, coupled with HIV, places these individuals at
an increased risk for suicide.
The chemically dependent person enters the medical
setting with a well developed denial system and selfdestructive behaviors.

Attempts at cognitive restructuring

for risk reduction behaviors, medical compliance and
adaptive coping are made extremely difficult.

The addictive

habits which served to conceal the anxiety and depression in
their lives prior to HIV are revisited during the early
stage resulting in relapse. Unfortunately, the HIV disease
with its debilitating processes eventually forces compliance
when they lose ability to physically, cognitively and
economically care for themselves.
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Women constitute the fastest growing subset of the AIDS
pandemic in the United States.

HIV disease is more

complicated, less understood and more misdiagnosed for women
than any other subgroup.

Very little literature exists for

this population as most research and clinical trials have
focused on the homosexual/bisexual male.
beginning to change.

But this is

A study in Milan, Italy investigated

the psychosocial problems of 71 HIV positive and negative
women.

The sample was of predominately single women,

average 26 years, who were actively using intravenous drugs.
Scales for anxiety, depression, social support and locus of
control were utilized.
The findings revealed little difference between the
groups.

In fact, those who were HIV seropositive had lower

levels of psychological morbidity.

However, the findings

did show that women with or at risk of HIV disease showed
high levels of anxiety, depression and distress with a
predominate external locus of control.

It also found little

use of condoms on a regular basis even for those infected.
This important area of concern brought highly recommended
psycho-educational interventions of counseling and support
for those settings where women at risk or HIV-infected
receive their medical care (Pergami et al., 1993).
Women, especially middle-class, heterosexual women do
not perceive themselves to be at risk for contracting the
HIV disease (Stentzner-Gibson, 1991).

As a result, the
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response to their diagnosis tends to include a more intense
denial with a decidedly heightened anger and rage.

Feelings

of betrayal from their partner can be overwhelming as can
the profound grief over the losses of their health, body
image, and childbearing potential.

Women with children have

the additional burden of guilt and fears for their
children's health and their future.
Suicidal ideation, with and without intent, among
persons with AIDS is many times greater than that of the
general public (Cohen, 1990; Wadland & Gleeson, 1991;
Ferrando, 1992).

Levine et al.

(1991) states that among

patients with catastrophic disease, HIV patients have
reported the highest suicide risks.

McKegney and O'Dowd

(1992) studied suicidality in their Psychiatric Consultation
Service in a medical hospital.

Their data indicated a lower

level of suicidality among patients with AIDS compared to
early stage HIV patients.

The organicity level with

delirium and dementia in AIDS patients enhanced the use of
denial, an association reported over decades.

Another

factor is that the fear of uncertainty in early HIV is
eliminated with the diagnosis of AIDS, allowing the person
to begin facing and mastering his fears of death.
Features that contribute to the risk of suicide are
feelings of hopelessness, impulsivity, substance abuse,
illness, loss and grief, all now layered with the diagnosis
of HIV.

The premorbid history of depression and suicide
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attempts increases that risk.

But for others, suicide as a

future option is an attempt to take control of one's own
destiny.

THEORETICAL FRAMEWORK FOR INTERVENTIONS

Several models for coping with stressful life events
were found in the literature (Hobfall & Wolfisch, 1986;
Shontz, 1975; Silver & Wortman, 1980).

The models appear to

share similar patterns and stages with a consensus on
several facts: 1) people respond to crisis in specific,
predictable ways - shock, anger, depression; 2)

individuals

go through a series of stages over time in attempting to
come to terms with their aversive life events; and 3) people
experience affective mood distress and anxiety.
In a theory of cognitive adaptation to threatening
events, Taylor (1983) found in her research with breast
cancer patients three dominant themes:
1)

a search for meaning of the event;

2)

attempts at regaining mastery and control over the

event and over life in general; and
3). an effort to restore one's self-esteem through
self-enhancing activities.
It is suggested that successfully resolving these
concerns begins with the creation and maintenance of a set
of illusions.

These illusions are not intended to distort
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reality, but cognitively reframe the facts in a particular
light that promotes both the courage and the will to
continue on in the face of adversity.

A goal then of

clinicians is to consistently appeal to the cognitive
capabilities of the patient.

Goldstein (1990)

found that

"effective practice is less a technical enterprise than it
is a creative, reflective, and to a considerable extent, an
artistic and dramatic event"

(p. 38).

Cognitively creating

and maintaining hope for a cure, treatment, and time is a
necessary goal (illusions) for HIV-infected people living
with liminality (on the edge) .
Perry et al.

(1990) studied the effectiveness of three

psychoeducational interventions on newly HIV tested
individuals.

The subjects were randomized to either

standard counselling, six weeks of individual sessions of
stress inoculation training, or three weeks of 45 minute
video programs.

Using self report and observer rated scales

including the Beck Depression Scale, the study indicated
that six week individual sessions with stress reducing
techniques were most effective in reducing depression and
anxiety.

He concluded, however, that the difference in the

response for each format may change in the different stages
of the infection.
Cognitive approaches at reducing anxiety and depression
for newly diagnosed people were the focus of a study by
Wolcott and Fowzy (cited in Levine, et al., 1991) who found
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that a ten week psychoeducational support group proved more
effective as an intervention than a psychotherapy drop-in
group.

Levine et al.

(1991) found their twenty week session

psychoeducational group had very positive outcomes measured
by improvement on the Hamilton Depression and Hamilton
Anxiety Scales.

They also found the group experience most

helpful in the promotion of and participation in medical
research protocols.
Namir et al.

(1987) evaluated the relationship between

different coping strategies and the psychological and health
status of people with AIDS.

They found that those who

engaged in avoidance coping had a higher level of depressive
symptoms, while those using active behavioral strategies had
a lower mood disturbance.

Most importantly, they found that

strategies that focus on the maintenance of self-worth will
increase feelings of control and combat passive, helpless
feelings and despair (p. 326).
The sum of all variables for coping with HIV disease
lies in the challenge and capacity to live daily with the
illness.

Siegel and Krause (1991) was the only study that

qualitatively examined this issue with HIV-infected people
in the pre-AIDS stage.

The themes that emerged from the

data provided three broad adaptive categories:
1). dealing with the possibility of a curtailed life
span (creating a sense of urgency to obtain life goals,
deciding to what extent to invest in the future) .
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2). dealing with reactions to a stigmatizing illness
(deciding whom to tell about their diagnosis, and
dealing with feelings of shame and contamination) .
3). developing strategies for maintaining physical and
emotional health (control and vigilance about one's
health) .
In looking at factors that influence the adaptive
process for chronic illness, Turk (1979)
meaning.

focused on personal

He felt personal meaning is created in a triad of

interplay between the individual person, the illness and
environmental factors.

The patient's appraisal of his or

her situation and its ascribed meaning is translated into
behavioral responses back to the environment.

It is

important to realize that this dynamic is constantly
changing and is bidirectional, with each element acting on
the other.
The situational appraisal of control and coping are the
two mediating processes in Lazarus and Folkman's (1984)
theory on stress and coping.

When a situation is appraised

as controllable, the coping tends to be more planful with
decreases in emotional distress.

Conversely, the more

uncertain and ambiguous the situation and less controllable,
the more likely the use of emotional-focused coping, and
increased distress.

Folkman et al.

(1993) examined the

coping appraisals of 425 gay men who completed self-report
questionnaires by mail.

They found that those who assessed
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their situation as controllable used active strategies in
coping and showed decreased depressed mood, while those who
appraised their stress as low on controllability used
escape-avoidance coping and had increased depressed mood.
The combined impact in the earlier stages of HIV of
personal meanings of demoralization and fears and the
growing uncertainty in treatment choices suggests the need
for interventions that enhance perceptions for situational
appraisals and strategies for survival with the current
societal stresses.

STRESS INOCULATION MODEL
The stress inoculation model is a therapeutic
intervention aligned with cognitive behavioral modification
(CBM) or cognitive behavioral therapy (CBT) .

This widely

adopted form of psychotherapy has been evolving since the
1970's.

CBT combines the basic principles of cognitive

therapy with behavioral activities to invoke adaptation and
change in a short-term therapy format

(Meichenbaum, 1992).

Basic principles of CBT recognize that behavior is
reciprocally determined; that emotions drive personal
schemas; that behavior is phenomenologically oriented; and
that collaboration and discovery processes are critically
important.

Other psychotherapeutic techniques subsumed

under CBT are cognitive restructuring, problem-solving,
anxiety management training and self-instructional training
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(p. 115) .

CBT has proven to be an effective intervention for
generalized anxiety, depression, phobias, panic disorders,
psychosomatic illness and pain control (Beck, 1993;
Chambless & Gillis, 1993).

The literature indicates a

growing interest in this approach for therapeutic
intervention for depression with people with HIV (Fishman,
1990, cited in Beck, 1993; Kelly et al., 1993).

This is

also true for the application of stress inoculation training
for HIV populations (Perry, 1991).

However, the literature

supports a wider application of the stress inoculation
training for anxiety, anger, posttraumatic stress disorders
for rape victims, and surgical preparations in the general
population.
Meichenbaum (1983) found there is an affinity between
the transactional model of stress and the stress inoculation
approach.

The intervention procedures assist individuals in

gaining the skills needed to manage and reduce stress, alter
cognitions and develop adaptive behavioral coping strategies
to reduce emotional distress (Kelly et al., 1993).

Berlin

(1983) found that the CBT analysis of coping suggests "that
the transactions between people and their environment are
primarily in the form of information exchange"

(p. 1097)

For people coping with the stress of a life-threatening
illness

the transactions include the patient, the illness

and the environment.

Due to the changes in life styles that
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add to the etiology of disease incidence and prevalence, and
to the growing interest in psychosomatic illnesses and
stress research, applications of this model in the medical
setting have been growing.
The stress inoculation model was developed to assist
patients in the health care setting as a means of preparing
them to cope with stressful medical situations.

Janis

(1983) defined stress inoculation as a procedure that
"involves giving people realistic warnings, recommendations
and reassurance to prepare them to cope with impending
dangers or loss"

(p. 67).

This procedure of preparation can

vary on a range of intensity from brief verbal and/or
written instructions to a well formulated training program.
A program inclusive of graded exposure to the stressful
situations with skill enhancing coping strategies will help
to reduce emotional distress and create opportunities for
personal control.
Interest in helping people psychologically prepare
themselves in dangerous situations began with Janis's
military experience in World War II.

His focus was on

reducing battle fatigue and he coined his intervention
"battle inoculation," later changed to "stress inoculation."
An intervention for combat readiness would certainly include
the affect of rage to off-set the paralysis of fear.

People

with HIV are "battling" an unspeakable foe and were it
contained, rage might be an appropriate strategy for coping.
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Janis (1983) felt that any preparatory communications
are said to function as stress inoculation if it enables a
person to increase his or her tolerance for subsequent
threatening events.

When successful, the process is called

stress inoculation because it may be analogous to what
happens when people are inoculated to produce antibodies
that prevent disease.

Strategies for living daily with HIV

could thus be seen as psychological antibodies against the
stressful assault of this illness.
A growing body of literature on the diverse use of
stress inoculation training (SIT)

(Blythe & Erdale, 1986;

Diffenbacher, 1988; Janis, 1983; Meichenbaum & Cameron,
1983; Perry, 1991) identifies the unique and complementary
strengths of the theoretical concepts.

These include the

rational restructuring and systematic desensitization
interface of cognitive and behavioral therapy.

The stress

inoculation model is based on a collaborative effort in the
cognitive reframing and reconstructing of the problem toward
solutions that promote personal control and adaptive coping.
Meichenbaum and Cameron's (1983) general stress
inoculation training paradigm was developed as a skills
training approach to anxiety management.

Their paradigm

contains three phases - educational, skills training, and
application - that with modification can be applied to HIV
seropositive patients in their pre-AIDS stage of disease:
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Education/Conceptualization
1) begin to restructure and reframe cognitive schema of
the HIV virus on a continuum creating hope.
2) break down the stressors of the disease into
specific behaviors and reactions.
3) educate the patient and significant other on the
nature and impact of stress.
4) challenge myths about alternative treatments with
more realistic expectations that allow for strategies
for healthy life styles and adaptation.
5) educate on legal and community resources that
promote personal control and empowerment.
Skills Acquisition
1) explore current coping and how it affects the
current situations.
2) provide problem-solving skills directed at
modification, avoidance and minimization of "triggers"
that produce stress.
3) palliative coping for dealing with uncertainty,
i.e., self-talk, passive relaxation training.
Application and Rehearsal
1) preparation of use of coping skills through
discussion of disclosure, employment dialogue, and
physician visits with behavioral rehearsal.
2) use of graded exposure with HIV slides and
discussion materials from physician and nurse
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3) homework which might include self-talk phrases,
relaxation techniques, journals.
Janis's (1983) use of stress inoculation on surgical
patients indicated that preparatory information can
inoculate people to withstand the disruptive and emotional
reactions to surgery.

In his review of other medical uses,

he found this technique does not apply to all situations and
the success of inoculation attempts will vary depending on
the nature of the stress.

Another recognized success of

preparatory training is seen in the widely used Lamaze
technique for childbirth.
Diffenbacher (1988) felt that "the best treatment fit
would be to match the characteristics of the intervention to
the most salient aspects of the patient's anxiety"

(p. 94).

Clearly, the need exists for expansion of clinical
interventions in reducing the emotional stress of HIV in the
medical setting, especially methods of preparation that help
manage the deleterious effects of the physical,
psychological, and social impact of this disease.
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SUMMARY

The first two sections of the literature review
provides a description of the illness and the emotional
distress felt by HIV affected individuals in the early
stages.

The last section provides an integrative approach

for stress reduction through a model that promotes personal
control and empowerment.

The goal of understanding the HIV

disease is not a static event, but an on-going process that
begins at the earliest contact and continues as the symptoms
and disease progress.

CHAPTER III
METHODOLOGY AND PROCEDURES

When we listen, we forget;
When we read, we remember;
When we do, we understand.
Chinese Proverb

INTRODUCTION

This field research experiment was shaped by the true
experimental design with its elements of pretest-posttest,
randomization, and comparison groups.

The combined

characteristics of this design were ideal for providing
evidence for a cause and effect relationship between
variables (Yegides & Weinbach, 1991) .

The rigorous controls

for validity have made this the most widely used of the
experimental designs (Campbell & Stanley, 1963).
This study was designed to test the effectiveness of a
biopsychosocial educational program entitled "Living with
HIV" which was based on a cognitive-behavioral approach
utilizing the "stress inoculation model."

It was developed

as an intervention for stress reduction and survival for
people battling the HIV disease in the pre-AIDS stage.
Patients

living with the stress created by this
45
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life-threatening illness need help navigating the maze of
medical, legal, emotional and social reactions they
experience daily.

This program provides strategies as a

first line of defense in training individuals to anticipate,
prevent and cope with the emotional distress of being
HIV-infected.

METHODOLOGY OF THE STUDY

This study examined the dependent variables of
depression, anxiety, internal health locus of control, and
medical compliance, against the independent variable a
biopsychosocial educational program.

The study subjects

were randomized between experimental or control groups and
participated in the pre-and-post assessment scales.

INDEPENDENT VARIABLE

"Living with HIV" is a model developed for this study.
Its content is based on the major biopsychosocial issues
identified through clinical observations in the early stages
from a medical, social, legal and psychological perspective.
This program was facilitated by a clinical social worker and
included speakers from both the clinic and community.

This

interdisciplinary group included an infectious disease
physician, psychiatrist, clinical nurse specialist, social
worker, nutritionist, lawyer, and a representative from the
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Social Security Administration.

The goals of the program

were threefold:
1.

Promote medical education, medical compliance and
risk reduction behaviors.

2.

Enable patients to exercise more control over
their health by becoming informed consumers of
health care issues and services while forming
decision-making partnerships with their Health
Care Team.

3.

Provide skill enhancing techniques for adaptive
coping and reduction of emotional distress.

This program utilized the stress inoculation model of
preparation for future threatening events and was balanced
with a supportive relationship with the health care team,
significant others, and community.

The agenda for the six

weekly sessions of ninety minutes per session consisted of
the following:
SESSION 1. Introduction to "Living With HIV" Program

A. Program Overview
Speaker: Social Worker
1.

Goals, Purpose and Methods

2.

Confidentiality

3.

Resource Packets

B. Introduction to the HIV Clinic
Speaker: Clinical Nurse Specialist
1.

Overview of Clinic Structure and Operations

48

2.

Clarification of Clinic Services

3.

Nursing Role in Clinic Services

4.

National Clinical Trial Center

5.

HIV Service Team Inpatient Defined

SESSION 2. Medical Management of HIV Disease

A. Introduction to HIV Health Issues
Speaker: Infectious Disease Physician
1.

Promoting a Partnership in Health Care
Treatment Decisions

2.

HIV 101 - Basic Knowledge

3.

Primary and Secondary Prevention

4.

Interpreting Laboratory Results

5.

Strategies for Healthy Lifestyles

SESSION 3. HIV Nutrition

A. Introduction
Speaker: Dietician
1. Rationale
2. Nutrition and Immune Function
B. Nutrition Throughout HIV Infection
1. Prevention
2. Restorative
3. Supportive
4. Palliative
C. Strategies For Improving Nutritional Status
1. Normal Nutrition
2. The Role of Each Nutrient
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3. Water, Vitamins and Minerals
4. Special Considerations
5. Supplements
6. Ways to Increase Calories /Protein
7. Food Safety, Drug-Nutrient Interactions
8. Alternative Therapies
D. Activity Table
1. Food Recall and Pyramid
2. Supplement Tasting
3. Food Safety Quiz
SESSION 4. Legal Issues I Social Security

A. HIV Legal Issues
Speaker: Lawyer/AIDS Legal Council
1. Discrimination Laws: ADA
2. Confidentiality Laws
3. Power-of-Attorney: Health & Property
4. Estate Planning
B. Social Security Entitlements
Speaker: Social Security Representative
1. Review of benefits -Title II, SSA and SSI
2. Eligibility Criteria
3. Process of Claims and Appeal
SESSION S. Resources for Empowerment

A. Health Insurance
Speaker: Clinical Social Worker
1. Understanding Managed Care: Traditional, HMO,

50

PPO, POS, Self Insured and Individual Policies
2. Understanding your Medical Coverage
3. Federal and State Insurance Coverage Medicare,
Medicaid and ICHIP
4. Cobra Laws - 18 Months vs 29 Months
Ryan White Funds - ICHIC
B. Additional Resources
1. Federal Drug Reimbursement Program
2. Compassionate Use Programs
SESSION 6. Handling Feelings and Stress

Speaker: Psychiatrist
A. Identifying Stress
1. Predisposition to Stress
2. Coping with feelings and defenses
3. Common Emotional Concerns
4. Getting Help for Stress
B. Techniques for Stress Management
Speakers: Psychiatrist/Clinical Social Worker
1. Relaxation and Imagery
2. Self-Statements to Enhance Coping
3. Strategies for Living Daily with HIV
The sessions concluded with a review of some of the
strategies for living daily with HIV with encouragement for
participants to continue to build upon these for
self-enhancement and empowerment (See Appendix C)

In

addition, a Program Evaluation was completed by those in
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attendance at the last session (See Appendix C) .

SAMPLE
The sample for this study consisted of nineteen (N=19)
HIV seropositive adult patients registered with the
Comprehensive HIV Clinic within a hospital setting.
Eligibility for the study required that patients be
diagnosed in the early stage of the HIV disease by their
physician and be new to the clinic within the past six
months.

Other criteria for inclusion were: 1) CD4

(T-helper

cell) count of greater than 200; 2) no evidence of
opportunistic infections that define progression to AIDS;
and 3) patients with a history of chemical dependency must
have been in recovery for a period of three years.
This clinic population of adults at risk for HIV
disease was representative of national norms with a majority
of the patients being homosexual but with increasing numbers
of intravenous drug users and women.

A smaller number of

hemophiliac patients completed the risk groups in the
clinic.

Patients seek medical interventions at various

points on the clinical HIV continuum from those newly
diagnosed and asymptomatic to those further progressed and
symptomatic, to those with full-blown AIDS.
Recruitment for the study involved the posting of
notices defining the study and its criteria at the clinic
reception desk and the patient waiting room.

In addition,
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physicians informed those patients who were eligible about
the study during their clinic visits.

Discussing research

protocols with patients was standard practice at this clinic
due to the clinic's participation as a national clinical
trial site.
Unfortunately, at the time of recruitment the clinic
experienced a majority of new patients further progressed in
their illness leaving a smaller number eligible for this
study.

The nature of the disease with its high element of

uncertainty and unpredictability, along with the
individual's idiosyncratic response to the virus and medical
intervention, resulted in diagnostic changes from a pre-AIDS
status to AIDS.

Therefore, in an attempt to maintain

criteria for inclusion in the study, the time frame for
measuring the efficacy of the independent variable was set
to five months.
Initially, 22 subjects agreed to participate, giving
eleven (N=ll)

in the experimental group and eleven (N=ll) in

the control group.

However, one subject (female) in the

experimental group attended only one session and was then
lost to follow-up after repeated attempts to make contact.
Additional adjustments to the sample were made at the
post-test period of time due to further attrition of two
subjects (males) in the control group.

One subject had

moved out-of-town and the other was lost to follow-up.
Again, numerous attempts to contact them were made without
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response.

Of the three subjects, two were less than 35

years old, and two had less than 500 CD4 counts.
Furthermore, two subjects in the experimental group had
completed both the pre and post tests but didn't attend any
sessions; they became part of the control group.

This left

a final sample configuration of eight (8) in the
experimental group and eleven (11)

in the control group for

a total of nineteen (N=19) study subjects.

CONFIDENTIALITY
A major ethical concern when conducting research was
the protection of the individual's confidentiality regarding
their participation and response in a research project.
From the beginning of the HIV crisis scientific research in
the form of clinical trials had been the main source of
medical intervention for HIV-infected people. The social and
legal risks involved with this population in research had
created state and federal laws for their protection.

In

addition, professional disciplines carried their own
standards of ethical practice.
To protect the confidentiality of those in the study,
the following steps were taken.

All subjects were given a

code number after agreeing to participate in the study.
Their code numbers, along with their name, social security
number and telephone numbers, were kept on a master list and
locked in a confidential location and destroyed at the end
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of the study.

Personal information was needed for contact

for pre and post test appointments as well as medical chart
review for three months following the posttesting.
For those randomized to the program, first names only
were used.

Participants and their guests signed their first

names on name tags used throughout the program.

Finally,

subjects were reassured that none of the research data would
be included in their medical charts.
Ethical and moral considerations for research with
human subjects in a hospital setting carried strict
requirements and guidelines for conducting this study.

Of

major importance were concerns for confidentiality and for
the methodological steps to be taken to protect other
patient rights.

Applications for this project were

submitted in a required format and processed by three
separate offices. First, the University's Office for the
Protection of Research Subjects Institutional Review Board
gave its approval for the use of human subjects for research
purposes.

Second, the Research Office and Research

Committee of the hospital gave their approval for both
scientific and administrative use.

And thirdly, approval

for this study was also sought and approved by the
Institutional Review Board at Loyola University of Chicago
(see Appendix E) .
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SETTING
The setting was in a large medical teaching center in
its Comprehensive HIV Clinic (CHC) in a major midwestern
city.

This Clinic offered primary care and was a national

clinical trial site with approximately 600 patient visits
per month.

The medical care was managed by a

interdisciplinary staff which included infectious disease
physicians, post doctorate fellows, psychiatrists, nurses,
social workers, a dietitian, a respiratory therapist, and a
phlebotomist.

In addition, consultation services were also

available in the Clinic from an oncologist, neurologist and
ophthalmologist.

Appointments for the study interviews

often coincided with clinic visits or work schedules and
were held in the Clinic in private rooms to insure
confidentiality.

The study program "Living with HIV" was

also held in the clinic conference room to accommodate
participants and their guests.
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INSTRUMENTS

The process of quantifying the dependent variables for
this study involved both self-report and observer rated
instruments.

Hamilton (1976) advocated for the observer

rated process over the self-report.

He felt it had

theoretical advantages as observers were more likely to
"penetrate the mask which patients tended to use to hide
their symptoms"

(p. 58).

Corcoran and Fischer (1987)

reported that quantification was beneficial in work with
patients because it allowed you to monitor change
mathematically.

It was this presentation of change scores

that created the interpretive process for clinical
significance.
The purpose of this study was to examine the
effectiveness of the program (independent variable)
comparing the experimental and control groups in a
measurement of change scores over time.

Seven instruments

were utilized beginning with the descriptive demographic
data collected from the subjects and their medical records
that included: sex, age, ethnicity, marital/partner status,
education, employment, risk category, CD4 count and date of
diagnosis.
following:

The psychological measurements included the
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THE BECK DEPRESSION INVENTORY:

Inventory (BDI)

The Beck Depression

(Beck, et al., 1961) was a self-administered

21 item scale designed to measure the severity of depressive
symptoms with four alternative statements rated from O to 3.
It had a score range from 1-63.

The conventional cutoff

score of greater than thirteen (13) was used with other HIV
studies (Perry, et al., 1993).

This depression scale was

subjected to numerous tests to determine its reliability and
validity.

Internal consistency between the individual

category scores and total scores was significantly beyond
0.001 level (Beck et al., 1961) and a split-half reliability
coefficient (r

=

0.93).

This psychological measurement had proven its
appropriateness over time with a high level of utility,
sensitivity, and directness in measuring manifested
behaviors hence its overall suitability for the context of
this study.

However, the somatic items composing a portion

of the BDI (e.g., fatigue, appetite loss and insomnia) may
have reflected physical disease rather than depression (See
Appendix D) .
THE HAMILTON DEPRESSION RATING SCALE:

Depression Rating Scale (HAMD)

The Hamilton

(Hamilton, 1976) was a 17

item scale rated on 3 to 5 point scale

designed to assess

depressive illness as a self-report or observer rated
measurement.

This study used the observer rated method

following the 17 item Structured Interview Guide (Williams,
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1988).

This scale gave details on specific symptoms (e.g.,

suicidal ideation on items 7, 8, & 9) and identified
different degrees of severity of depressive illness.

A

score of greater than thirteen (13) usually marked clinical
depression.

In combination with the BDI, the literature

reported a high correlation in validity between the use of
the two scales (HAMD=0.84; BDI=0.77)

Reliability for the

HAMD is 0.88 (See Appendix D).
THE HAMILTON ANXIETY RATING SCALE:

Anxiety Rating Scale (HAS)

The Hamilton

(Hamilton, 1969) was an observer

rated scale consisting of 14 biological descriptions
designed for the rating of generalized anxiety states.

The

symptoms are bipolar, splitting them into two subscales
between psychic (7) and somatic (7) .

Studies linking the

HAS to diagnosis of generalized anxiety disorder used a

cutoff score of greater than or equal to fourteen (14) and a
median of twenty-five (25) for the DSM-IIIR Posttraumatic
Stress Disorder (Beck et al., 1984; Perry et al., 1993)

(See

Appendix D) .
THE IMPACT OF EVENT SCALE:

Scale (IES)

In The Impact of Event

(Horowitz, Wilner & Alvarez, 1979) each subject

was asked to complete this 15 item self report instrument
designed to measure the stress associated with traumatic
events.

The authors intentionally did not define the event,

but left this to the observer and respondent at the point of
instructions on use.

This instrument measured two
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categories of response to traumatic events in subscales:
intrusive (7) experiences such as images, troubled dreams

and waves of feelings; avoidance (8) experiences such as
conscious awareness of avoidance of certain ideas, feelings,
meanings and their consequences (Horowitz et al., 1979).
A revision of this scale resulted in the current 15
item scale with a split-half reliability of the total score
(r=0.86).

Additional internal consistency of the subscores

using the Cronbach's Alpha indicated intrusive at 0.78 and
avoidance at 0.82.
reliability of 0.87.

The measure had a test-retest
This instrument's overall

appropriateness included elements of utility in its use and
scoring, suitability to the context of the population being
studied, sensitivity to observation of change over time, and
finally in its directness in capturing the signs of living
daily with a life-threatening illness.

Scoring for the IES

in several recent studies had led to a selection of a score
of twenty (20) as a cutoff for either subscale.

Scores

above twenty on either subscale were strongly predictive of
a significant stress response and a DSM-IIIR Posttraumatic
stress disorder (Cella et al., 1990)

(See Appendix D).

THE MULTIDIMENSIONAL HEALTH LOCUS OF CONTROL SCALES:

The Multidimensional Health Locus of Control Scales (MHLC)
(Wallston et al., in press) was a recent expansion of the
MHLC referred to as Form C.

It differed from Form A and B

in that the health condition was mentioned with the
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instructions.

Inserting HIV for the word condition added

face validity and utility to this measure. Its design was to
measure eighteen items of patients' belief regarding control
over their health concerns from an internal Locus of Control
(6), from chance (6), and from powerful other that further
divides between the physician (3) and other (3).

This study

focused only on the scores for internal, and powerful
others, which included physician and significant other.
This 18 item self report measure used a 6-point likert
format ranging from strongly disagree to strongly agree
scores.

The MHLC had been revised from a unidimensional to

a multidimensional scale improving the reliability of the
internal consistency utilizing the Cronbach's alpha between
0.67 to 0.77.
validity.

This additional scale increased the criterion

Total scores in each category indicated the level

of effect HIV has on the subject (See Appendix D) .
THE MEDICAL REVIEW LOG:

The Medical Review Log (MRL)

was a form created for this study to log both the
experimental and control groups medical compliance for a
period of three months following completion of the
biopsychosocial education program and posttesting.

Included

on this form were the date of review, compliance per
participant of scheduled clinic appointments, along with
medication (oral, intravenous or aerosol) and specialty
compliance.

The major focus for this study was the

participants compliance with clinic appointments.

The
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appointment book and medical charts were reviewed placing a
Y (Yes) and N (No) for indication of compliance and NA (not
appropriate) if appointment was not scheduled.

No

information was added to the patient's chart nor shared with
other clinic staff members (See Appendix D) .

PROCEDURES

Notices of the study describing its purpose and
criteria were posted at both the reception desk and patient
waiting room in the Clinic that included the project
investigator's (PI) name and telephone number for contact
(See Appendix A) .

The same information about the study was

also given to those patients who met criteria from their
physician during their clinic appointment.

At the point of

contact further explanations of the study were given and an
appointment for pretesting was scheduled.
Participation in the study was voluntary and patients
were not paid a fee.

However, for those randomized to

attend the program, the clinic provided a small grant to
cover parking fees and light refreshments.

Due to location

and parking difficulties those subjects and guests traveling
by car received stickers for the hospital parking facility.
And with the time of the program in the early evening, light
refreshments approved by the dietitian were provided.
A master list was developed that included the code
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number, name, social security and telephone number of each
subject as appointments were made (See Appendix A).

This

personal information was necessary for making contact for
scheduling pre and post testing, maintaining attendance at
the "Living with HIV" program, and identification of medical
charts for the three month review.

This master list was

kept in the locked desk of the PI and destroyed at the end
of the study.

Randomization for this study was by code

numbers as appointments were made and completed.
Individual appointments for the pretesting were made to
accommodate the subjects' clinic or work schedule.

Prior to

data collection all subjects signed an informed consent to
participate in the study (See Appendix B) .

First the

demographic information was obtained that included sex, age,
ethnicity, marital/partner status, education, employment,
risk category, CD4 count, and date of HIV+ diagnosis (See
Appendix D).

Next a set of psychological inventories, both

self-administered and observer rated, were given in the
following order: the Beck Depression Inventory (BDI),
Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety
Rating Scale (HAS), Impact of Event Scale (IES) and the
Multidimensional Health Locus of Control Scale (HLOC)
Appendix D) .

(See

Total time for this process was less than 55

minutes.
At the completion of the pretest data collection,
randomization between the experimental and control group was
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done by code numbers.

Those with odd numbers were

experimental, and those with even numbers were control.

The

experimental group was given a schedule with the dates,
time, and location for the program.

In addition, each

program participant was encouraged to invite up to two
guests per session for the purpose of building support among
their significant others.

A secondary gain from such a

program was the possible disclosure of patients' HIV medical
situation to loved ones.

Though this was not an issue being

examined in this study, it represented an interest of the
investigator.

Those randomized to the control group were

assured exposure to the program and informed the program
would be repeated at the conclusion of the study and they
and their guest would be invited to attend.

In addition,

all support services offered to clinic patients were
available upon request.
The experimental intervention ''Living with HIV" began
one week after completion of the last interview.

The

importance of attending all six sessions was emphasized as a
means of achieving the program's goals.

It was expected

that illness of the study participants might prevent
attendance.

In fact, illness was given as a reason for two

of the participants missing the final session.

However, the

illness of the PI who was also the facilitator and speaker
for the fifth session resulted in the group's decision to
double up the last two sessions of Resources for Empowerment
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and Handling Feelings, rather than adding an additional
week.

Participants were asked to contact the PI if they

were unable to attend a session or if guests were not
attending.
For those unable to attend a session the PI provided
the participant and/or guest an outline and materials
covering the topic of discussion.

Non-attendance or missing

more than three sessions significantly detracted from the
program goals and its possible effectiveness on outcome
measures.

Two subjects who did not attend any sessions but

completed pre and post test were excluded from the original
experimental group assignment and thus included in the
control group.
Sensitivity to the need for confidentiality of those
attending the program was maintained by using first names
on everyone's name tag.

The program was held in the CHC

Conference Room for comfort and to accommodate the speakers'
audio and visual equipment needs.

Resource packets with

medical and community resources were given to each
participant and their guests at the first session.
Additional materials and resources from each session were
then added to the packets.

At the concluding session a

program evaluation was available to the six subjects in
attendance as were appointments for posttesting.

Telephone

contacts were made to all others to arrange for posttesting
appointments.
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At the posttest the subjects once again completed the
psychological inventories that included: the Beck Depression
Inventory (BDI), the Hamilton Rating Scale for Depression
(HAMD), the Hamilton Anxiety Rating Scale (HAS), the Impact
of Events Scale (IES) and Multidimensional Health Locus of
Control Scales (HLOC) .

The average time frame for

completing the posttest was less than 45 minutes.

At the

conclusion of the assessments, any comments given by the
subjects about the materials and/or program in addition to
the evaluation were noted.

The control group was informed

of the next scheduled "Living with HIV" program and invited
to participate.

This was scheduled after the chart reviews.

The three month medical chart review began at the
conclusion of the posttest.

This study was assessing the

medical compliance of all study subjects based on adherence
to their clinic appointments.

Patients' were given medical

appointments based on their individual medical condition
and CD4 count, recognizing that not everyone was scheduled
on a monthly basis.

The Medical Review Log indicated

compliance for scheduled appointments.

It also looked at

agreed upon medications and specialty referrals.
Information was obtained from the patients' medical
records verified by name and social security number kept in
the CHC record room.

The physicians procedure notes were

gleaned for compliance during the three month period of
time.

A clinic procedure for recording missed appointments
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was a stamped notice in the medical charts, which provided
attendance information for the study.

All compliance

information was noted on the Medical Review Log (See
Appendix D) developed for this study by placing a Y (Yes) or
N (No) or NA (Not Applicable) beside each category for each
participant for three months.
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RESEARCH HYPOTHESES

This study was designed to examine the effectiveness of
a stress inoculation model to reduce emotional distress for
HIV-infected people in their pre-AIDS stage through the four
hypotheses listed below.
Hypothesis 1:

Participation in a biopsychosocial

educational program will result in a decrease in
anxiety in the experimental group compared to the
control group.
Hypothesis 2:

Participation in a biopsychosocial

educational program will result in a decrease in
the mood disturbance of depression in the
experimental group compared to the control group.
Hypothesis 3:

The experimental group will show

increased levels of locus of internal control
versus physicians' and others' control as a result
of their participation in the biopsychosocial
educational program in comparison to the control
group.
Hypothesis 4:

Participation in a biopsychosocial

educational program will result in an increase in
medical compliance among the experimental group
compared to the control group for a period of
three months following the completion of the
program.
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DATA ANALYSIS AND INTERPRETATIONS

Descriptive and inferential statistics were used in the
analysis of the demographic data and the four research
hypotheses for this study.

To begin with, it was customary

to compile and present a summary description of the
characteristics of the research sample into group form
(Yegides & Weinbach, 1991) .

The descriptive analysis began

with frequency tables by total sample then by groups to
provide demographic differences and similarities of the
sample under study.

The Fisher's Exact Test of Association

for small samples was utilized. Summation of the demographic
characteristics further defined the sample participants in
this study.
Inferential statistics were used to analyze the four
study hypotheses utilizing the raw scores from the
assessment instruments.

The analysis focused on the pretest

versus posttest change scores between the experimental group
compared to the control group.

The most widely used

acceptable test for looking at change scores was the t test
with the analysis of covariance to level the pretest score
(Campbell & Stanley, 1963).

This study utilized the

parametric t test for small samples with equal-interval
data.

The student's t test of significance began with the

measurements of differences on assessment scales within the
groups utilizing the correlated paired t test for dependent
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samples.

This measured whether the differences from

prescores to postscores within the experimental group and
within the control group were different from zero.
The second application of the t test was to test the
differences between groups utilizing the pooled t test for
an independent two sample case.
separate comparisons to consider.

This procedure provided two
The first compares

differences between groups in their mean change from
postscores minus the prescores.

The second procedure

compared differences in mean change of the experimental
versus control groups for pre scores, or post scores.
Finally, an analysis of covariance (ANCOVA) permitted
"a post-hoc, statistical control for one or more concomitant
variables, removing their influence from the comparison of
groups on the experiment factor"

(Hays, 1994, p. 811).

This

statistical procedure was a way of testing the effect of the
research experiment by adjusting for any equality of the
prescore values.

This study used the SAS System for Linear

Models computer package.
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LIMITATIONS OF THE STUDY

Inherent in all research studies is the awareness of
limitations that affect the generalizability of its results.
This study was no exception with limitations that involved:
1) a smaller sample size meeting criteria during
recruitment, 2) adjustment to the "Living with HIV" program
schedule, 3) sample attrition and adjustments to the size
and group configuration, 4) attendance at the program, and
5) intervening effects of changes in the subjects' medical
status and the influence of others.
The study experiment was dependent on the program
content, materials, order of presentations and the abilities
of the speakers to promote coping, adaptation and
empowerment.

Assessing the impact on change scores as a

result of the independent variable for this population
raised limitations on outcome results.

For it was

recognized that the media impact in reporting scientific
failure, concerns over health care coverage, and the
stigmatization of the HIV-infected populations during this
time could not be controlled for its effects on outcome
measurement.

In addition, the idiosyncratic responses of

the study subjects to their level of infection during the
program suggested further implications for changes in
emotional distress.
The ability to assess emotional distress within this
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population at this stage of adjustment recognized a
limitation to the study methods.

Ongoing efforts to manage

anxiety and depressive symptoms through medications external
to the study were not identified or accounted for in this
study.

Though it might not have been a reason for exclusion

for the purposes of this study, this undoubtedly would have
added insight to the outcome data.
Such limitations did not diminish the importance of
this biopsychosocial intervention as a vehicle for coping
and surviving for HIV-infected people in the earlier stage
of the disease.

It further encourages replication that is

content appropriate for the setting, population and stage of
the illness.

CHAPTER IV
PRESENTATION AND ANALYSIS OF DATA

"Whether reducing distress or decreasing the risk of
suicide is meaningful is a matter of values. By the
same token, defining the minimum amount of change
necessary to be meaningful is also a matter of values"
(Hollon & Flick, 1988, p. 203).

INTRODUCTION
The purpose of this chapter was to report the results
of the investigation of the effectiveness of the independent
variable ''Living with HIV", a biopsychosocial educational
program.

The study findings for this chapter were divided

into three sections: 1) descriptive data, with subject
characteristics and frequency findings, 2) inferential
statistics, analysis using the t test, and 3)

subjective

responses, participants' feedback on the study.
The quantitative findings for this study were generated
in three distinct time periods.

The first time period

yielded the data collection of the demographic information
followed by the pretest psychological assessments scales.
These scales were designed to measure depression, anxiety,
impact of the event of HIV disease and health locus of
control.

Subjects were asked to respond to the assessment
72
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questions based on their feelings and experiences from the
past seven days.

The instruments included the Beck

Depression Inventory (BDI), the Hamilton Depression Rating
Scale (HAMD), the Hamilton Anxiety Rating Scale (HAS), the
Impact of Event Scale (IES), and the Health Locus of Control
Scale (Form C)

(HLOC) .

All participants completed the

scales.
The second time period began at the completion of the
study intervention that consisted of a six week
biopsychosocial educational program entitled "Living with
HIV".

This program began in January and was completed in

February, 1994.

At the conclusion of the program, nineteen

participants were again administered the same five
assessment scales as a post-test measurement.

The third

time period began at the completion of the post-test and
involved a three month medical chart review to assess the
participants' medical compliance.

Charting of study

compliance measurements were made on a form created for this
study called a Medical Review Log.
The subjective response of the participants to the
study experience was generated at the completion of the
study.

The experimental group was asked to complete a

program evaluation on the last night of the program.

Six

participants attended and completed the evaluation.
Responses are reported here, however, any clinical
significance this might add is presented in the next chapter
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on discussion and implications of the study.

DESCRIPTIVE DATA AND ANALYSIS

Demographic information was collected on all 19
subjects at the pretest time period that included sex,

age,

ethnicity, marital/partner status, education, employment,
risk factor, CD4 count, and time of diagnosis.

The

following presentation and charts are a descriptive analysis
of the demographic characteristics of the sample.

SUBJECT CHARACTERISTICS
The sample's age ranged from 25 to 46 years, with a
mean age of 34.4 (SD= 6.14).

Sixteen percent

(N=3) were in

their twenties, sixty-three percent (N=l2) in their thirties
and twenty-one (N=4) in their forties

(See Figure 1).

The majority of the sample were men, eighty-four
percent (N=l6), which is consistent with national norms for
this disease.

Sixteen percent (N=3) were female.

The

ethnicity of the sample consisted of sixty-eight percent
(N=l3) Caucasians, twenty-one percent (N=4) African-American
and eleven percent (N=2) Hispanic

(See Figure 2) .

Educational achievement was evident in this sample with
a median education level of 16, which represents a college
degree (range 12-19 years) .

Twenty-six percent (N=5)

completed their education with their high school diploma.
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FIGURE 1: AGE
PARTICIPANT DEMOGRAPHICS
40 - 46 Years

4

25 - 29 Years

3

30 - 39 Years

12

FIGURE 2: ETHNICITY
PARTICIPANT DEMOGRAPHICS
Caucasian
13

Hispanic
2
African-American
4
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Ten percent (N=2) had at least two years of college and ten
percent (N=2) had completed three years of college.

Further

education consisted of thirty-three percent (N=6) who
completed a college degree. And twenty-one percent (N=4)
achieved graduate degrees with two at the masters level and
two doctorate of law degrees (See Figure 3).
A majority of the sample reported they were employed
with seventy-four percent (N=l4) working full-time,

ten

percent (N=2) as part-time and sixteen percent (N=3) as
unemployed.

Of those unemployed, one was a housewife and

one was a full-time graduate student.
In terms of marital/partner status, seventy-four
percent (N=l4) defined themselves as single.

Eleven percent

(N=2) were married, and eleven percent (N=2) had live-inpartners.

And four percent (N=l) were widowed.

In terms of

risk factors for HIV, eighty-four percent (N=l6) reported
their risk factor as homosexual, again meeting national
norms as the major risk group.

Sixteen percent (N=3)

reported heterosexual contact as their risk factor (See
Figure 4).
Normal CD4

(T-helper cells) counts for healthy

individuals was 1000, with a plus or minus 500.

The CD4

count was a direct measure of the immunologic status of
HIV-infected individuals and was considered the most
important marker of the disease progression.

Since the CD4

count declined during the course of illness, antiretroviral
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FIGURE 3: EDUCATIONAL
ACHIEVEMENT
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therapy was now suggested to patients with a CD4 count of
less than 500.

With less than a 200 CD4 count, therapy to

prevent or control pneumocystic carinii pneumonia was
initiated.
At the time of the data collection the samples' CD4
(T-helper cells) counts were as follows: twenty-one percent
(N=4) were between 201-300; thirty-two percent (N=6) were
between 301-400; twenty-one percent (N=4) were between
401-500; ten percent (N=2) were between 501-600; and sixteen
percent (N=3) had greater than 601 CD4 counts (See Figure 5)
Finally, HIV seropositive people entered the medical
system at different stages on the HIV continuum due to a
variety of factors.

Among these factors were delayed

testing, change in medical services or denial.

The

following variability in the time since diagnosis in this
sample supported this view: fifty-eight percent (N=ll) had
been diagnosed less than a year; eleven percent (N=2)
diagnosed one to two years; eleven percent (N=2) diagnosed
three to four years; sixteen percent (N=3) diagnosed five to
six years; and four percent (N=l) diagnosed more than six
years (See Figure 6) .
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GROUP CHARACTERISTICS
The demographic characteristics were divided into a 2x2
contingency table for evidence of association with the
Fisher's Exact Test for small samples.

They are presented

first from a total sample perspective (see Table 1),
followed by experimental and control group (see Table 2).
The findings provided evidence of significant differences
between groups at the p < .05 and p < .07 levels.
These demographic findings suggested some divergent
patterns between the experimental and control groups.

An

example of differences was seen with age, education, CD4
count and the time of diagnosis.

For instance, comparing

those under 35 to those over 35 years old, the experimental
group had seventy-five percent (N=6) under and twenty-five
percent (N=2) over the age of 35.

This compared to the

control group with forty-five percent (N=5) under and
fifty-five percent (N=6) over 35.

Fisher's exact two-tail

test was 0.352 significant at p < .05 .
The educational level was divided for this sample
between low education (high school plus some college) and
high education (college plus) .

The experimental group had

thirty-eight percent (N=3) low and sixty-two percent (N=5)
high.

This compared to the control group with fifty-five

(N=6) low and forty-five

(N=5) for high resulting in a

Fisher's Exact Test of 0.650 (two-tail test) at p < .07.
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TABLE 1.

SAMPLE DEMOGRAPHIC FREQUENCIES

Sample Characteristics

N

%

SEX

Male
Female

16
3

84
16

AGE

less than 35
greater than 35

11
8

58
42

ETHN

Cauc
Other

13
6

68
32

M/P

Single
Other

14
5

74
26

EDUC

Low
High

9

10

47
53

EMPLOY

Full
Other

14
5

74
26

RISK

Gay
Other

16
3

84
16

CD4

less than 500
greater than 500

14
5

74
26

TOD

less than 1 Year
greater than 1 Year

11
8

58
42

M/P
TOD
CD4

Marital Partner
Time of Diagnosis
T-Helper Cells
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TABLE 2.

DEMOGRAPHIC FREQUENCIES BY RANDOMIZED GROUPS

Characteristics

Experimental

Control

n

%

n

%

Male
Female

7
1

88
12

9

2

82
18

AGE

less 35
greater 35

6
2

75
25

5
6

45*
55

ETHN

Cauc
Other

4
4

50
50

9

2

82
18

M/P

Single
Other

8
0

100
0

6
5

55
45

EDUC

Low
High

3
5

38
62

6
5

55
45*

EMPLOY

Full
Other

6
2

75
25

8
3

73
27

RISK

Gay
Other

7
1

88
12

9

2

82
18

CD4

less 500
greater 500

8
0

100
0

6
5

55*
45

TOD

less 1 Yr
greater 1 Yr

7
1

88
12

4
7

36*
64

SEX

Fisher's Exact Test
*Significant at ~ < .05 - group differences
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The CD4

(T-Helper cells) count was divided between less

than 500 or over 500 CD4 counts.

The experimental group had

100 percent (N=8) under 500, compared to the control group
which had fifty-five percent (N=6) under and forty-five
percent (N=5) over 500.

Results of the Fisher's Exact Test

of 0.045 (two-tail test) was significant at p < .05.
Finally, the time of diagnosis was divided between
those diagnosed less than a year and those greater than a
year.

A significant difference was seen with eighty-eight

percent (N=7) less than a year and twelve percent (N=l)
greater than a year in the experimental group.

This

compared to the control group with thirty-six percent (N=4)
less than a year and sixty-four (N=7) greater than a year.
Measurement on the Fisher's Exact Test of 0.037 (two-tail
test) was significant at p

<

.05.

SUMMARY OF DESCRIPTIVE DATA
To summarize the demographic frequency by total sample
there were heterogenous patterns beginning with the number
of males (84%) versus females

(16%).

The reported major

risk factor was due to homosexual (84%) as against
heterosexual (16%) partners.

The ethnicity of the sample

was caucasian (68%) and African Americans (21%) and Hispanic
(11%) .

Age was divided between those under 35 (58%) and

those over 35 (42%) .
The majority of the sample defined themselves as single

84
(74%) with married, partners and widowed at (26%) .
working full-time
working at (26%) .

Those

(74%) were compared to part-time or not
Subjects who were diagnosed HIV positive

less than a year (58%) were compared to those greater than a
year (42%).

And finally, at the time of the study those

with CD4 counts of less than 500

(53%) were compared to

those with CD4 counts greater than 500 (47%) .
Specific demographic variables that included age,
education, CD4 count and time of diagnosis provided
information suggestive of sample trends.

For instance, the

experimental group was younger (75% vs 45%), had higher
educated members (62% vs 45%), had a lower CD4 count at the
time of the study (100% vs 55%) and finally, had been
diagnosed HIV positive within a shorter time period of less
than a year (88% vs 36%) than the control group.

The

possible influence these sample trends had on the outcome
data has yet to be established.
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INFERENTIAL STATISTICS

Four hypotheses provided focus for this study.

These

hypotheses were stated in the positive form and tested for
significance at the P

<

.05 level.

The analysis of the four

stated study hypotheses focused on the change scores between
groups and within the experimental group for any reliable
change.

Measurements for change used the t-test for

dependent and independent small samples with Analysis of
Covariance (ANCOVA) as a statistical control.

The data

analysis begins with two tables reporting group measures of
psychological distress.

The first table reported means and

standard deviations (see Table 3), and the second reported
means and mean change scores (see Table 4).

This was

followed by reviewing each study hypothesis and its
corresponding psychological assessment scores (Hypotheses 1,
2 and 3) and the medical review log (Hypothesis 4).
The goal of this research analysis was to test whether
the "stress inoculation model", a model of preparation,
could serve as a vehicle for reducing emotional distress.
And to do so, by investigating change scores for indications
of stress reduction and coping improvements.

Recognizing

that with a disease as threatening as HIV, change even in
small increments improved one's quality of life.
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TABLE 3.

MEASURES OF PSYCHOLOGICAL DISTRESS BY GROUPS

TEST

EXPERIMENTAL ( 8)
PRE
POST
M
SD
M
SD

CONTROL (11)
PRE
POST
M
SD
M
SD

BDI

13.87

8.6

12.75

5.0

8.72

6.1

9.09

8.5

HAMD

16.00* 6.8

12.00

4.7

12.81

6.7

12.45

8.6

HAS

15.50* 7.6

15.12*

4.9

13.54

9.7

12.54

8.1

ISEI

15.62

4.9

16.75

3.0

12.00

5.8

13.36

4.2

ISEA

18.00

5.9

20.75*

3.4

13.63

5.3

14.36

4.4

HLOCI

23.37

5.4

20.62

4.6

19.81

6.0

18.63

6.5

HLOCD

14.37

4.5

14.25

4.2

13.54

4.8

13.36

4.1

HLOCO

10.50

3.6

9.12

2.5

9.81

2.8

10.18

3.4

*HAMD: fourteen or greater indicates depressive symptoms.
*HAS:
fourteen or greater indicates generalized anxiety.
*ISEA: twenty or greater indicates post-traumatic stress.
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TABLE 4.

MEASURES OF PSYCHOLOGICAL DISTRESS WITH CHANGE

SCORES BY GROUPS

TEST
PRE

EXPERIMENTAL
CHANGE
POST
SCORE

CONTROL
PRE

POST

CHANGE
SCORE

8.72

9.09

0.35

BDI

13.87

12.75

-1.12

HAMD

16.00**

12.00

-4.00*

12.81

12.45

-0.36

HAR

15.50

15.12

-0.37

13.54

12.54

-1.00

IESI

15.62

16.75

1.12

12.00

13.36

1.

IESA

18.00

20.75

2.75

13.63

14.36

0.72

HLOCI

23.37

20.62

-2.75

19.81

18.63

-1.18

HLOCD

14.37

14.25

-0.12

13.54

13.36

-0.18

HLOCO

10.50

9.12

-1.38

9.81

10.18

0.37

* Paired t-test at -2.29 ( one-tail test), P < .05.
**HAMD: fourteen or greater indicates depressive symptoms.
Change score = post score minus pre score.
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STUDY HYPOTHESES
In this subsection the results of the hypotheses
testing are reported.

To measure change over time, the

correlated t-test and pooled t-test with the statistical
control of ANCOVA were used.
at P

<

Level of significance was set

.05.

Hypothesis 1:

Participation in the biopsychosocial

educational program ''Living with HIV" will result in a
decrease in anxiety in the experimental group compared
to the control group.

Measuring anxiety as a reaction to stress was obtained
from two scales, the Hamilton Anxiety Rating Scale (HAS) and
the Impact of Event Scale (IES).

The Structured Interview

Guide (Sigh-AD) was utilized in the administering of the
HAS, an observer rated scale for this study.

The potential

range in score was 0-56 with the cut-off score of fourteen
(14) for generalized anxiety disorder and a median of
twenty-five (25)
Syndrome.

for the DSM III-R Posttraumatic Stress

A higher score indicated higher anxiety.

Table 5 presents the HAS means distribution by sample
and by group.

By sample, fifty-three percent (N=lO) met the

criteria for generalized anxiety disorder in both pre and
post test with fifty percent (N=4)
and fifty-five percent (N=6)

in the experimental group

in the control group.

The data
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for the experimental group reported a higher level of
anxiety than the control group with only a slight decline in
the postscore.

Their scores on both pre and post scales

were above the cut-off of fourteen and highly suggestive of
the diagnosis of generalized anxiety disorder during the
study.

Two of these subjects had positive change scores

with decreases in their anxiety scores (20-14; 23-12).

One

participant showed an increase in anxiety state with an
increased score (13-19).

Scores for the control group for

both pre and post tests were below the cut-off score of
fourteen.

TABLE 5.

They showed a slight decline in the post-test.

DISTRIBUTION OF GROUP MEAN SCORES ON THE HAMILTON

ANXIETY SCALE

PRE TEST
Range
Mean

SD

Range

POST TEST
Mean

SD

ALL (N=l9)

1-36

14.36*

8.78

0-25

13.63

6.90

EXPERIMENTAL

4-27

15.50*

7.67

9-25

15.12*

4.90

CONTROL

1-36

13.54

9.79

0-23

12.54

8.10

* HAS: score of fourteen or greater indicates generalized
anxiety disorder.

Analysis of the correlated t-test (t=-0.160) within the
experimental group and the pooled t-test (t=0.193) between
groups was not statistically significant.

This supported
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the null hypothesis that there was no decrease in activity
between the experimental group compared to the control
group.

The ANCOVA statistical control found no differences

in mean values after adjusting for the HAS prescore.
The HAS assessment for Posttraumatic Stress Syndrome
using the median score of twenty-five (25) found the sample
(N=l9) with a 15.00 for both pre and post scores.

The

control group had a median prescore of 15.00 and a postscore
of 16.00 with an increase of 1.0.

The experimental group

had a median prescore of 15.00 and a postscore of 14.50
showing a decrease of -0.50.

Scores by groups did not meet

the criteria for Posttraumatic Stress Disorder, but did so
by two individual scores.

One (13%) in the experimental

group had a prescore of twenty-seven, and a postscore of
twenty-five.

And one (9%) in the control group had a

prescore of thirty-six and declined to eighteen in the
postscore.

Both subjects' scores are suggestive of the DSM

III-R diagnosis for Posttraumatic Stress Syndrome during the
study.
Table 6 provided a second look at the HAS but through a
modified version of this bipolar scale.

Here the scale

allowed a measurement of the psychic features separate from
the somatic symptoms.

Of interest were postscores of the

experimental group indicating change in the cognitive
reframing of events as promoted with the stress inoculation
model.

After eliminating items under the somatic subscale
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that could be present because of the direct physiological
effects of HIV infection, i.e., genitourinary,
gastrointestinal, autonomic, cardiovascular, and respiratory
symptoms, a seven item psychological subscale was left. It
had a rating of 0-4 per item with a possible range of scores
from 0-24. The subscale for psychic features included
anxious mood, tension, fears,

insomnia, cognitive, depressed

mood, and behavior during the interview.
table displays the

The following

postscores of the subscale that included

both psychic and somatic features for comparisons.

TABLE 6.

SCORES, MEANS AND STANDARD DEVIATIONS FOR HAS POST

SUBS CALES

EXPERIMENTAL (N=8)
Score
Mean
SD

CONTROL (N=ll)
Score
Mean

SD

PSYCHIC

93

11.62*

3.50

94

8.54

5.50

SOMATIC

25

4.16

1.72

51

5.10

3.20

*pooled t-test (t = -1.394 one-tailed test) p < .05

Table 6 outcome data did not provide enough evidence to
show

the experimental group had less anxiety than the

control group using the modified HAS.

Psychological

distress rather than somatic disturbances of the HAS
appeared to represent the major response for this
HIV-infected sample.

This was particularly evident in the
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experimental group where tension was rated highest with
feelings of restlessness, startled response and easily moved
to tears as most identifiable to their experiences.
The Impact of Event Scale (IES) was a fifteen (15) item
self-report scale developed to assess the subjective impact
of a stressful life event.

The scale was recognized for its

sensitivity to detect change in clinical status over time.
The items were divided into subscales with seven (7)
intrusion and eight (8) avoidance items.

It had a response

choice of: Not at all, Rarely, Sometimes, and Often, with a
range in score from 1-60.

Being HIV-infected was the

defining stressful life event appropriately inserted for
this study at the point of assessment.

A score above twenty

(20) on either subscale on the IES was strongly predictive
of a significant stress response and a DSM III-R
Posttraumatic Stress Syndrome diagnosis.
Table 7 presents the score range, mean and standard
deviation of the pre and post scores for the two items of
intrusion and avoidance by group.

Again, the data suggested

a higher stress response in the experimental group compared
to the control group.

The experimental group showed a

broader range in scores and a higher level of intrusion and
avoidance in their reported subjective responses.

The

experimental group had five (63%) and the control group had
six (55%) subjects above the cut-off in at least one
subscale for the pre and post scores.

For both groups,
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avoidance maneuvers scored higher than intrusive thoughts.

TABLE 7.

MEANS AND STANDARD DEVIATIONS FOR GROUP IMPACT OF

EVENT SCALE

EXPERIMENTAL (N=8)
RANGE MEAN
SD

CONTROL (N=ll)
RANGE MEAN
SD

INTRUSION/PRE
INTRUSION/POST

9-24
12-21

15.60
16.70

4.9
3.0

7-22
7-19

12.00
13.36

5.8
4.2

AVOIDANCE/PRE
AVOIDANCE/POST

8-26
17-26

18.00
20.75*

5.9
3.4

8-25
8-23

13.63
14.35

5.3
4.4

* t= 3.38 (one-tail test), p < .05
* t= 2.65 (one-tail test), p < .05

Pooled t-test
AN COVA

The correlated t-test to assess differences within the
group was not significant.

However, the pooled t-test to

assess differences between the groups was significant in the
post avoidance.

When applying the analysis of covariance

control an increase in mean values of avoidance in the
experimental group was again significant after adjusting for
the pretest.

Increases instead of the anticipated decreases

in stress response were found in the experimental group.
The study hypothesis was attempting to replicate the
stress response theory with an oscillating declining pattern
between intrusive thoughts met with avoidance maneuvers in a
downward spiralling effect.

The data indicated the opposite

for both groups with increasing intrusive thoughts met with
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increased avoidance maneuvers.

For the experimental group,

the level of avoidance was more intense in comparison to the
level of intrusive thoughts.
Data on the HAS, the modified HAS and the IES scales
appeared to indicate the groups were more alike than
different.

The mean scores for the experimental

gr~up

tended to display higher levels of anxiety and stress
compared to the control group.

The hypothesis for decreased

anxiety in the experimental group attending the "Living with
HIV" program compared to the control group was not supported
by the outcome data.

Hypothesis 2:

Participation in the biopsychosocial

educational program "Living with HIV" will result in a
decrease in the mood disturbance of depression in the
experimental group compared to the control.

Once again two scales were used to measure mood
disturbance, the Beck Depression Inventory (BDI) that was
self-administered and the Hamilton Depression Rating Scale
(HAMD) that was observer rated.

The BDI is a self-

administered twenty-one (21) item scale designed to measure
the severity of depressive symptoms.

The scale has four

alternative statements per question with a range in score
from O to 63.

The conventional cut-off score of greater

than thirteen (13) was used to indicate the presence of
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depressive symptoms (Perry et al., 1993).
Table 8 presents mean scores with range and standard
deviation by sample and group.

By total sample, both pre

and post scores were below the cut-off score for depression.
Sixty-three percent (N=5) of subjects in the pretest in the
experimental group, and thirty-eight percent (N=3) in the
posttest met the criteria for the presence of depression.
The mean change score of -1.125 indicates a decline in
depression for the experimental group.

TABLE 8.

DISTRIBUTION OF GROUP MEAN SCORES ON THE BECK

DEPRESSION INVENTORY SCALE

PRE TEST
Range Mean

SD

POST TEST
Range Mean

SD

ALL (N=l9)

1-24

10.89

7.5

0-25

10.63

7.0

EXPERIMENTAL

2-24

13.87

8.6

2-19

12.75

8.1

CONTROL

1-22

8.72

6.1

0-25

9.09

8.1

Of those meeting criteria for depression in the control
group there were eighteen percent (N=2) in the pretest and
forty-five percent (N=4) in the posttest.

A decline in

depressive symptoms in the experimental group was seen in
the mean change scores between groups and within their
group.

The pooled-t-test between groups had a mean change

score of -1.125 with P

<

.6360.

The correlated paired
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t-test had a mean change score of -1.125, and a P < .6658.
The ANCOVA's were not statistically significant nor were the
t tests.
The Hamilton Depression Scale HAMD was a 17 item
observer rated scale.

Utilizing The Structured Interview

Guide (Sigh-AD) the scale had a 0-1 (per 4 items), 0-2

(per

6 items) and 0-4 (per 7 items) and a range in score between
0-44.

The scale was designed to assess depressive illness

and gave details on specific symptoms (e.g., suicidal
ideation 7, 8, 9 & 10) with different degrees of severity.
A score greater than thirteen (13) usually marked clinical
depression.

Reliability for the HAMD was 0.88.

In

combination with the BDI the literature reported a high
correlation in validity between the use of the two scales
(HAMD=0.84; BDI=0.77)

(Beck et al., 1984).

Table 9 presents the mean scores for HAMD for the
sample and by groups.

The total sample prescore was above

the cut-off score indicating the presence of depression, but
the postscore showed a decline.

The experimental group

reported a higher level of depressive symptoms than the
control group with a significant decline in the postscore.
The correlated t-test (t= -2.29 one-tail test) within
the experimental group was statistically significant at the
P < .05 level.
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TABLE 9.

DISTRIBUTION OF GROUP MEAN SCORES ON THE HAMILTON

DEPRESSION RATING SCALE

PRE TEST
Range Mean

SD

POST TEST
Range Mean

SD
7.1

ALL (N=l9)

1-23

14.15* 6.8

1-28

12.26

EXPERIMENTAL

4-22

16.00* 6.8

5-18

12.00** 4.7

CONTROL

1-23

12.81

1-28

12.45

6.7

8.6

* HAMD: scores fourteen or greater indicates depression.
**t= -2.29 (one-tail test), p < .05 paired t test.
ANCOVA between groups was not statistically significant.

A significant decrease in depression scores indicated
improvement for the experimental group.
changes

Their individual

went from seventy-five percent (N=6) in the

prescore to thirty-eight percent (N=3) in the postscore.
This compared to the control group who had forty-five
percent (N=5) in the prescore and forty-five percent (N=5)
in the postscores.
The use of the HAMD allowed a closer assessment of
suicide ideation (Q 7, 8,

9, & 10), a concern supported in

the literature for this stage of the HIV disease.

The

following is a frequency response to these questions for
both pre and posttest scores and by groups (E =
Experimental, C = Control):
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Q 7.

IS LIFE POINTLESS?

PRE

NO

5

( E)

8

( C)

I

YES

3

(E)

3

( C)

POST

NO

6

(E)

9

( C)

I

YES

2

(E) 2

( C)

Q 8. HAVE YOU THOUGHT OF ENDING IT ALL?

PRE

NO

2

(E) 7 (C)

I

YES

6

(E) 4

POST

NO = 6

(E) 10 ( C)

I

YES

2

(E) 1 ( C)

( C)

Q 9. HAVE YOU MADE PLANS TO KILL YOURSELF?

PRE

NO = 2

(E)

( C)

I

YES

6

(E)

2

POST

NO

(E) 11 (C)

I

YES

3

(E)

0 ( C)

5

9

( C)

Q 10.HAVE YOU ATTEMPTED TO - OR DO YOU INTEND TO -

KILL YOURSELF?

PRE

NO

6

(E) 10 ( C)

I

YES

2

(E) 1 (C)

POST

NO

7

(E)

I

YES

1

(E)

9

( C)

2

( C)

Those respondents who felt life was pointless did so in
the context of their HIV diagnosis.

Thoughts and plans for

ending their lives were statements that represented attempts
at control over future events.

Their expressed fears

focused on disease escalation and the inability to care for
themselves; this made life seem pointless.

Many referred to

deceased partners or friends and the witnessing of body
wasting and deterioration due to AIDS.
Ambivalence was evident in Question No. 10 over wanting
to control future events by their actions yet expressing
hope for a cure or control of the disease and the desire to
live.

Two respondents who answered yes to Question No. 10
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on the pretest had a history of suicidal attempts.

In the

posttest one subject in the experimental group had lost a
former partner to AIDS in the fourth week of the
intervention program.

All were referred for psychiatric

follow-up at the end of the post assessments.
Results of the outcome data from both scales assessing
the mood disturbance of depression indicated decreases in
the level of depression within the experimental group
between the pre and post scores.

Decline was also evident

in the number of subjects who met the criteria for
depression in the experimental group compared to the control
group. However, between the groups the decline was not
statistically significant.

Hypothesis 3:

The experimental group will show

increased levels of internal locus of control versus
physicians' and significant others' control as a result
of their participation in the biopsychosocial
educational program "Living with HIV" in comparison to
the control group.

The Health Locus of Control (HLOC) Form c (Wallston et
al., in press) was an 18 item self report instrument
designed to measure the individuals' beliefs regarding
control over their health concerns.

These concerns include:

internal locus of control (6), chance (6), powerful others
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divided between physicians (3) and others (3).

The word HIV

was inserted for the health condition in the assessment
scale.
This study was interested in the level of individuals'
sense of internal control over health issues as compared
with the effects that physicians and others have on them.
The subscale of chance was not included in this study.
Scoring was measured on a 6-point likert format from
strongly disagree to strongly agree.

Total scores in each

category indicated the level of effect HIV had on the
subject.
Table 10 reports a pooled t test comparing differences
between groups in their mean change from the post score
minus the pre score.

The data indicated both groups

experienced a decline in their internal locus of control
mean score.
The experimental group went from a 23.37 prescore mean
to a 20.63 postscore mean, while the control group started
at a lower prescore mean of 19.82 and declined to a
postscore mean of 18.64.

The influence of physicians on the

experimental group showed only a slight decline in both
groups.

The impact of significant others reversed positions

between groups. The post scores declined for the
experimental group and increased in the control group.
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TABLE 10.

BLOC POOLED T TEST MEAN DIFFERENCES BY GROUP

EXPERIMENTAL

INTERNAL
DOCTOR
OTHERS

MEAN

STD E

-2.75
-0.13
-1. 37

1.48
1.94
1.33

T-VALUE

P.VALUE

-0.852
-0.025
-1. 211

< 0.408
< 0.980
< 0.256

-0.874
0.027
-1.350

< 0.394
< 0.978
< 0.194

CONTROL
INTERNAL
DOCTOR
OTHERS

-1.18
0.18
0.36

1. 08
1. 06
0.52

Analysis of the correlated and pooled t-test, along with the
ANCOVA's were not statistically significant.

The data suggested a disparity between the experimental
and the control group's internal mean scores.

One sample

pattern of interest was that of the differences in the
length of time since the diagnosis.

Here time may have

represented an initial reaction and challenge for control,
and thus a higher internal score for those recently
diagnosed.

A lower internal score was seen with those

diagnosed for a longer period of time, perhaps a reaction to
the failure in scientific efforts.
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TABLE 11.

SUMMARY OF MEANS FOR HLOC BY TIME OF DIAGNOSIS

INTERNAL
MEAN
SD

DOCTOR
MEAN
SD

LESS THAN YEAR (PRE)

23.54

5.4

15.54

4.1

10.90

2.9

LESS THAN YEAR (POST)

20.72

6.3

14.45

4.2

10.00

2.8

GREATER THAN YEAR (PRE)

18.25

5.5

11.62

4.4

9.00

3.3

GREATER THAN YEAR (POST) 17.75

4.6

12.75

4.0

9.37

3.5

OTHERS
MEAN
SD

Table 11 presents the HLOC summary of means data by
time of diagnosis.

Change scores were evident in the post

test means for internal locus of control at -2.82 for less
than a year, and 0.50 for greater than a year.

Influence of

a doctor was -1.09 for less than a year, +1.12 for greater
than a year.

And finally, influence of significant others

was -0.90 for less than a year and 0.37 for greater than a
year.
Findings suggested those diagnosed less than a year
were more vulnerable to decline of internal locus of control
as compared with those diagnosed greater than one year.
When looking at sample trends and the possibility of
influence on outcome data these findings supported this
vulnerability.

In the experimental group seven (88%) were

diagnosed less than a year, and seven (64%) of the control
group were diagnosed greater than one year.

Further, at the
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time of the study, eight (100%) of the experimental group
had a lower CD4 count compared to six (55%) in the control
group.
One of the goals in this intervention program was to
create a partnership in health care decisions between
physician and patient.

The slight decline in belief of

physician as powerful other suggested some change in the
balance for health care decisions in the experimental versus
the control group.

The influence of significant others was

relatively stable between groups.
Results of outcome data did not support the hypothesis
of an increase in the experimental groups' internal locus of
control versus physicians' and others' control compared to
the control group.

In attempts to create a partnership in

health care decisions a slight decline in physician
influence did occur within the experimental group, but it
was not statistically significant.

Hypothesis 4:

Participation in the biopsychosocial

educational program "Living with HIV" will result in a
higher level of medical compliance among the
experimental group versus the control group for a
period of three months following the completion of the
program.
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The Medical Review Log (MRL) was designed for this
study to log medical compliance for a period of three months
following the completion of the posttests.

Medical charts

were identified and their progress notes reviewed for
evidence of clinic attendance.

From the physician

narratives evidence of treatment compliance in medication or
specialty referrals was also noted.

To chart compliance a Y

(Yes) or N (No) or a NA (Not Appropriate) was entered for
each subject within the three month time period.
The data was comprised of the number of appointments
completed, missed or not scheduled for three months.

The

frequency of medical appointments was based on the
individual's medical status, and therefore, not everyone was
scheduled on a monthly basis.

Each kept appointment allowed

for further assessment for compliance of medications and
specialty referrals.

For this small sample size, the

Fisher's Exact Test of association was utilized to compare
the groups.
Table 12 reports the frequency of appointments kept
during the three month time period.

Clinic appointments

scheduled and completed for the experimental group was 100%
for all three months.

The Fisher Exact Test for Association

for the experimental group had a p < .01.

This compared to

the control group who had a compliance rate of 56% in the
first month, 50% in the second and 0% in the third.
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TABLE 12.

FREQUENCY OF APPOINTMENTS KEPT FOR THREE MONTHS

BY GROUPS

MONTH 1
YES NO NA

MONTH 2
YES NO NA

MONTH 3
YES NO

NA

EXPERIMENTAL
APPOINTMENTS

8*+ 0

0

3+

0

5

6+

0

2

MEDICATIONS

7

0

1

3

0

0

6

0

0

REFERRALS

2

0

6

2

0

1

1

0

5

100%

100%

100%

CONTROL
APPOINTMENTS

5

4

2

5

5

1

0

6

5

MEDICATIONS

1

1

3

3

0

2

0

0

0

REFERRALS

2

0

3

0

0

5

0

0

0

56%

50%

0%

* Fisher's Exact Test 0.0052 p < .01 (one-tail test)
+ 100% Compliance with Appointments Scheduled
Medication treatment for the experimental group
indicated compliance with all agreed upon treatment for
three months.

The control group had compliance with three

out of four treatment plans.
two months of activity.

This response represented only

The inability to assess for the

third month was due to six failed appointments.
The experimental group received two specialty referrals
in both the first and second time period and one in the
third; all were compliant.

Two control subjects received
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specialty referrals during their first clinic visits and
showed compliance.

No referrals were made in the second and

none in the third period as appointments were not kept.
For the total three month period of scheduled clinic
appointments the data found compliance for the experimental
group at one hundred percent compared to forty percent for
the control group.

The Fisher's Exact Test was 0.0052

(one-tail test) significant at p

<

.01.

Assessing

compliance for medical care and decisions for treatment only
occurred during the clinic visit; therefore, attendance was
the major variable in assessing compliance for this study.
The results of the MRL for the three month period
following the "Living with HIV" program indicated that the
experimental group had a significantly higher level of
compliance in adherence to their medical appointments than
the control group.
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QUANTITATIVE SUMMARY OF FINDINGS
1.

There was no significant decrease in anxiety in the

experimental group compared to the control group as measured
on the HAS and the IES scales.
2.

There was no significant decrease in mood

disturbance between the experimental group and the control
group as measured on the BDI and HAMD scales.

There was

within the experimental group a significant decrease in mood
disturbance as measured on the HAMD scale.
3.

There was no increase in the internal locus of

control compared to physician and significant others control
for the experimental group compared to the control group as
measured on the HLOC-C scales.
4.

There was a significantly higher level of medical

compliance in clinic appointments and therefore prescribed
treatment in the experimental group compared to the control
group for a period of three months following the completion
of the "Living with HIV" program.
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SUBJECTIVE RESPONSES

PROGRAM EVALUATION
At the completion of the last session of "Living with
HIV" six study participants in attendance were asked to
complete a program evaluation (see Appendix C) .

The

evaluation offered questions for each of the six sessions
and requested comments on the materials and speakers.

Three

responses were offered for each question from: very much,
enough, and not enough.

A final question asked for their

overall feelings about the program in terms of what was
helpful and what was missing, to help guide future programs.
Session I. Introduction to the Program and HIV Clinic

The first question was assessing appropriate
preparation in information and scheduled time for attendance
at the program.
"enough".

Three answered "very much" and three

The second question asked if the overview of the

HIV Clinic as a medical resource was helpful.
"very much" and one "enough".

Five marked

General comments praised the

organization and materials as very informative.

One comment

was "how nice to take part - rather than just listening to".
Session II. Medical Management of HIV Disease

Question one asked if the presentation was helpful in
understanding the disease and treatment options.
marked "very much" and one "not enough".

Five

The second

question was assessing the discussion on healthy life styles
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and a partnership with the physician.
"very much" and one "not enough".

Again, five stated

General comments

indicated that they would have preferred two sessions on the
medical issues, not one.

However, they found the

information very helpful.
preferred more options.

Two felt it was too basic and
Three commented on how the material

was presented in a relaxed atmosphere.

This last comment

was important as the medical information covered the HIV
continuum from serioconversion to the final stage of AIDS.
Session III. Nutrition

One overall question for this session asked if the
presentation was informative enough to assess their eating
habits and encourage changes.

Four marked "very much", one

"enough", and one "not enough".

This was a favorite and fun

session for all with comments praising the speaker and her
presentation.

Two commented they were amazed at the food

they needed to avoid.
Session IV. Legal Issues/Social Security

This session was divided by subject and speakers.

The

first section of the instrument asked if the presentation on
the legal issues of being HIV seropositive was helpful in
understanding their rights.

Three responses were "very

much", one "enough", and two "not enough".

The second

section was designed to give an overview of entitlements
through social security for future planning.

The question

asked if the material on social security was helpful. Two
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felt it was "very much", and four "enough".

General

comments said the speakers were very informative.

Two

people expressed gratitude that the legal issues focused
more on rights than living wills as "people are more fearful
of losing their rights''.

One person found the social

security information confusing.
Session

v.

Resources for Empowerment

There was only one overall question for assessing the
presentation on insurance options and managed care as a
resource for planning health care needs.
"very much" and three "enough".

Three responded

General comments were that

insurance is so individual and difficult to understand.
Session VI. Handling Feelings/Stress Management

This session was divided between discussion on the
emotional response to being HIV affected and coping
strategies.

The first question asked if the session was

helpful in discussing how mood and emotions impact on coping
with HIV.

Three responded "very much" and three "enough".

The second question asked if the relaxation techniques and
self-statements were helpful strategies.
much", two "enough", and two "not enough".
appeared to be a favorite session.

Two stated "very
Again, this

Comments suggested that

it was helpful for one to know if they were OK, or needed
help.

Another stated "we all have our own ways, each is

interesting and all very individual."
The final question asked for an overall critique of the
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program and for comments on what they found helpful and what
was missing and should be included for future programs.

The

following are the six participants' responses, all made
anonymously:
How nice to have so much information presented in a
pleasant and concise manner.

I was given more than I

would have sought - this was great.

I feel aware.

I think for the psychiatrist/depression session you
should let participants fill out a mini questionnaire
which could be discussed so that people could decide if
they needed to get further help.
program.

This is a great

Perhaps good for very newly- diagnosed

patients, but for patients who have been HIV+ for a
length of time and have educated themselves on some
issues, some of the information could be more advanced.
I found the legal and insurance classes quite valuable.
Thank you.

I think the program is of valuable help for persons
dealing with HIV.
out.

This program has been well thought

I only wish a little more energy could have been

put into making the participants share their thoughts.
I'm very grateful otherwise and hope to be able to get
more people to come.
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The most important part of this program for myself was
to really take time and learn what was happening to me.
I think anyone living with HIV should be able to take
part in this program.

I found this program wonderful.
go if I need more information.

I now know were I can
I would urge anyone who

finds themselves dealing with HIV to take this course.
Back-up materials have been good.

I think most people

would like to have stayed longer rather than 1 1/2
hours - maybe two hours or three.

Overall program was excellent on getting to understand
issues that I wasn't clear on, or just did not know
about.

I believe this type of program is extremely

helpful for anyone starting an HIV situation, or even
at certain stages of this illness, just to keep up on
any new or ongoing issues.

I don't feel as lost

anymore. And the social worker as always was very
helpful in the process.

CHAPTER V
DISCUSSION AND IMPLICATIONS OF THE FINDINGS

The war on AIDS will be fought by primary care
providers and won by health educators.
(AIDS International Conference, 1993)

INTRODUCTION

The central purpose of this research was to determine
the efficacy of the clinical intervention "Living with HIV"
as a stress inoculation for the emotional distress of being
HIV positive and to evaluate its clinical importance to the
field of social work practice and research.

To achieve this

end it is important to first reflect back on the
quantitative results reported in Chapter IV.
fuller review and interpretation is needed.

Clearly, a
Through a

synthesis of the literature review and findings the clinical
significance of this study can be considered.
What do the findings reveal about the intervention
model of reducing emotional distress in the earlier stages
of HIV?

And how should the psychological responses for this

sample be interpreted?

Importantly, a review of the

methodology for this study may add to our understanding of
this research effort and help plan for future studies for
113
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this patient population.

And finally, how will the clinical

significance of this study inform social work practice?

CLINICAL SIGNIFICANCE

To begin with, the study was successful in producing
positive responses to the intervention "Living with HIV".
Foremost was the experimental group's statistically
significant findings for medical compliance.

Determining

effectiveness of a study can be done through quantitative
statistics that are significant, without necessarily being
clinically meaningful (Hollon & Flick, 1988) .

The response

to the fourth hypothesis suggests both determinants were met
and brings implications for clinical practice in the medical
setting.
The first goal of the study's intervention was to
promote medical education, medical compliance and risk
reduction behaviors.

The program strategy of graded

exposure to knowledge about the HIV disease with a focus on
cognitive reframing was meant to engage and motivate
individuals' responsibility in their own health care.
Promoting personal control in the health care setting would
begin to correct earlier negative experiences.

Many

individuals learned their seropositive status over the
telephone from a clinic or physician's office that they
engaged for testing.
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Siegel and Krauss (1991) reported that the need to take
control of one's health was among the major themes of their
qualitative study on HIV-infected gay men.

Lazarus and

Folkman (1984) suggested personal control was the
underpinning for situational appraisal in the stress and
coping theory.

Opportunities to enhance one's appraisal of

a stressful-life event would lead to a balance in coping
between planful and emotional focused coping.
Subjective responses from the program evaluation
supports both the literature and the outcome data.

Of major

importance was the insight into how the material was being
perceived.

Three participants commented that the medical

management session was presented in a relaxed atmosphere.
This session allowed the physician to be informal and to
create an atmosphere for dual dialogue on health concerns
and thereby provided a crucial model for future physician
and patient interactions.

Another commented on receiving

information in a "concise and pleasant manner".

And added

"I feel aware".
Adding to the sense of personal control were behavioral
strategies to reduce anxiety that of ten accompany clinic
visits.

In "battle inoculation training" Janis (1983)

felt

positive behavioral changes resulted from an improved sense
of self-efficacy that could help to reduce the disruptive
effects of fear.

Techniques in reducing stress for clinic

appointments involved a suggested list of questions and
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concerns on medications and their side effects as well as
inquiry on current HIV management.

Included were several

suggested self-talk statements to manage anxiety.

The

significance of the data as measured on the Medical Review
Log was very supportive of the study effort.

Keeping

individuals motivated and engaged in the health care system
allows them to take full advantage of advances in treatments
for HIV.

It also creates a framework for hope.

The second program goal focused on health internal
versus external control that would enable patients to
exercise more control over their health by becoming informed
consumers of health care issues and services while at the
same time forming decision-making partnerships with their
health care team.

A major concern for HIV-affected

individuals was the fear of losing access to health care.
In the era of health care reform, consumer education on the
myriad of insurance, legal, and entitlement issues was
addressed in the program.

Correlational data supports the

idea that HIV-affected individuals need to be informed of
the medical and legal ramifications of their illness for
access and control of their own destiny (Britton et al.,
1993; Folkman et al., 1993; Siegel & Krauss, 1991).
Measurement for health locus of control represented the
third hypothesis in the study.

The findings did not support

the anticipated increase in internal locus of control for
the experimental group over the control group.

In fact,
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both groups experienced a decline and were more alike than
different.

A change score indicating a decrease in

physician influence was seen in the experimental group.

In

two other studies (Kelly et al., 1993; Pergami et al., 1993)
comparison groups did not differ significantly in their
perceived locus of control.

An alternate analysis of the

data using the time of diagnosis with the level of perceived
internal locus of control, showed similar findings.

Those

diagnosed less than a year versus those greater than a year
had almost identical results.

This was due to the fact that

the experimental group had 88% diagnosed less than a year
compared to the control group with 64% greater than a year.
The findings for this sample suggested a stronger
external locus of control versus internal locus of control.
Another study came to the same conclusion, however, the
sample consisted of HIV positive and negative women (Pergami
et al., 1993).

It was suggested in Chapter IV that those

diagnosed HIV less than a year were more vulnerable to
decline.

Another implication is that the diagnosis of HIV

may stir up self-blame, self-hatred and internal homophobia
for some gay or bisexual men, thereby decreasing internal
trust and control (Cohen & Abramowitz, 1990).

The majority

of the sample represented a minority culture whose survival
had been more dependent on others than self.

Combining this

with the growing uncertainty of the medical care for HIV
expressed in the community and the media creates additional
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obstacles.

Finally, a possible influence on outcome data

may be the decision for a double session on the final night
of the program.
The third program goal was to provide skill enhancing
techniques for adaptive coping and reduction of emotional
distress.

The presence of emotional distress of anxiety and

depression for HIV-affected individuals in the earlier stage
has been well documented earlier in the literature review.
It was evident as well in the findings for this study.
Generalized anxiety for this sample tended to reflect
psychic or cognitive symptoms more than somatic ones.

In

another study with early HIV the psychic versus the somatic
yielded significant results, but at the three month
assessment period (Perry et al., 1991).

The experimental

group had a consistent pattern of higher emotional distress
scores than the control group.

And change scores provided

evidence of decreases in anxiety and depression within the
group rather than the expected changes between groups.
Cohen (1990) felt the ability to cope with the stress
and anxiety of being HIV-infected begins with a cognitive
appraisal of the crisis.

The study intervention utilizing

the stress inoculation model contained cognitive reframing
sessions for control of anxiety along with behavioral
skills.

What was not anticipated was the level of anxiety

created by attending this program.

Ninety minutes prior to

the first session of "Living with HIV", one female subject
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called to explain "I can't do it, I'm not ready to deal with
this yet".

She asked to attend the follow-up program and

offered to complete the posttest.

She became a part of the

control group.
At the start of the first session one male subject
related thinking about this program all day and feeling
almost too anxious to attend.

This resulted in a delay of

the program to allow other participants to verbalize their
anxiety in coming to the program.

A means of handling

feelings of stress and anxiety by requesting time-out was
agreed upon.

Interestingly, this defense maneuver was never

used.
When reviewing the results of the Impact of Event Scale
a noticeable increased use of avoidance maneuvers was seen
for the experimental group in comparison to the control
group.

One might suggest that the anxiety generated by the

program compounded the anxiety of being HIV-affected with
increasing defensive maneuvers.

Perhaps a more viable

explanation for the differences is found in the time of
diagnosis and CD4 counts between groups.

The experimental

group had been diagnosed a shorter period of time and had
lower CD4 counts compared to the control group.

Further,

the possibility of increased coping skills gained from the
program might have resulted in the lower intrusive thoughts
through stronger avoidance maneuvers.
The necessity to combine two topics in the final
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session raised concerns of influence on the data.
Discussing the complexity of insurance was anxiety provoking
on its own, but more so when it was vital to one's
existence.

Evaluation comments confirmed this belief even

though it provided participants important information.
However, the next topic on handling feelings and stress
appeared to be the favorite session.

It was also the last

session and termination issues were raised with the absence
of two participants.

The informality of the program design,

and the relaxed approach of the psychiatrist encouraged
interactions among the participants.

The difficult area of

disclosure of diagnosis to family was interweaved with the
stresses that confront the HIV-affected individual.

The

desire to talk about feelings resulted in less time for
rehearsing imagery and self-talk behavioral strategies.
The subjective responses on the last session included a
sense of loss and desire to continue in some other form.
Several participants referred to the sessions as "classes"
and to each other as "classmates''.

One participant stated

"it was helpful to know your (sic) doing OK, or in need of
help."

This comfort in discussing feelings was repeated in

the observer rated Hamilton Depression Rating Scale at the
posttest.

The outcome data yielded a statistically

significant decrease in depressive symptoms within the
experimental group.
The current dialogue in psychotherapy over the ability
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to assess "reliable change" or ''clinically significant
change" was reviewed in the literature (Hollon & Flick,
1988; Hsu, 1989; Jacobson & Revenstorf, 1988).

Reliable

change began with statistical formulas developed as a post
hoc measurement for assessing the significance of change
scores using the absolute value for the instruments.

This

approach posed problems for studies with multiple scales
making it unclear how to assimilate discrepancies between
scales (Jacobson, 1988) .

For this study the clinical

significance is assessed less from quantitative findings and
more from the subjective responses and actions of the
participants.
In defining clinical significance or meaningfulness
Hollon and Flick (1988) felt the ultimate criterion is
really a matter of values.

A reduction in anxiety or

depressive symptoms is meaningful to the person involved.
This is especially true for chronically ill population.

For

example, being capable of entering a medical clinic without
feeling panic, is valuable.

Feelings of empowerment when

advocating for one's legal rights to benefits, entitlements
and access to care, is valuable.

And the enhancement of

personal control through a partnership in medical
decision-making promotes dignity.

This is valuable.
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PARTICIPANTS' CLINICAL RESPONSE
The participants' subjective responses and actions
ultimately defined the meaningfulness or clinical
significance of this study intervention.

Upon completion of

the study, four of the eight experimental subjects began
individual and group counseling through the hospital's
outpatient mental health service·s.

The study appeared to

have served as a vehicle for linking patients in need of
additional psychological services.

Further responses to the

psychological instruments found that they served as an
intervention for change also.

The following examples were

shared at the conclusion of the posttest:
#002

(control)

He stated after the first assessment he

felt the materials were depressing, yet found it
mobilizing him into action.

First, he decided that he

was too anxious and tense at work and needed to
reevaluate his work style.

He met with his supervisor

to help prioritize and pace his work assignments.

He

then followed through on a referral and saw his
physician regarding his sleep disturbance.
on medication and reports doing better.

He is now

Finally, he

made an appointment to have his eyes examined and found
little change and decided it was stress and anxiety.
He stated that being part of the study helped him to
resume doing things for his health that he had done
before, but had become complacent about.
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#021 (experimental)

He stated after completing the

pretest that he was too tense and had to slow down at
work and not be so compulsive.
work pace and style.

He, too, changed his

He felt the scales helped him to

develop a new attitude about taking care of himself.
#010

(control)

Upon completion of the scales he was

informed of the next scheduled program.

He was very

relieved, stating he thought he had failed on the first
scales and would not be included.

His scores met

criteria for clinical depression, anxiety and
posttraumatic stress disorder.

He had been referred

for counseling and informed the researcher of a pending
appointment and plan to start group therapy.
grateful for the study.

He was
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METHODOLOGICAL IMPLICATIONS

The fact that the present study was based on such a
small sample suggests caution in the interpretation of the
results.

The anticipated sample size was not achieved as

the majority of CHC patients, new to the clinic, were in
more advanced stages than the study required.

Even so, the

study criteria for selecting research subjects was
maintained, as it supported the literature on the earlier
stages of the HIV disease.

The demographic characteristics

of the sample provided a profile of HIV-infected individuals
at the time of recruitment.

The inclusion of the CD4 count

and the time of diagnosis supported both the stage of
disease and the variability in time of diagnosis when
seeking medical care.

It was anticipated that this added

dimension might be a contributing factor to the level of
emotional distress.

The reported findings indicate this to

be the case more for the experimental group than the control
group.
This research study followed the principles of the
classic experimental design, or Design 4 for hypothesis
testing (Campbell & Stanley, 1963).

Its rigorous

characteristics of pretest-posttest, independent variable,
control groups, and randomization were intended to equalize
the comparison groups and any threats to validity.

A review

of some extraneous sources of variability for this study for
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possible threats to internal and external validity had
methodological implications for the study intervention and
its responses.

INTERNAL VALIDITY ISSUES
In determining the effects of the independent variable,
Monette et al.

(1986) felt "the central issue in

experimentation is its utility in enabling us to make
statements about causal relationships between phenomena"
226).

(p.

The experience of being HIV-infected would most

likely manifest itself equally among the experimental and
control groups.

However, the likelihood for bias of

maturation occurring is a concern with this "at risk"
population.

In the experimental group one subject

experienced a major loss with the death of a former partner
during the fourth session.

One would anticipate that this

significant loss amplified the loss that comes with a
diagnosis of HIV-positive and had a direct effect on the
dependent variables from pretest to posttest.

This subject,

who chose to remain in the study, responded yes to the
question of "intent to kill yourself" at posttest.

However,

at the completion of the study he revealed alcohol problems
not revealed previously, and accepted and began individual
counseling shortly thereafter.

The quantitative data for

this subject was affected as was the clinical significance.
The testing process produced a reaction to the
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instruments at the pretest that served as an intervention
for change.

This was reported after the posttest by three

subjects from both study groups.

This dramatic reaction, as

described previously under clinical significance, was a
surprise to the researcher.

On one hand it raised questions

of undue influence on outcome data, while on the other hand
it provided answers to a moral dilemma with the study
design.

An ethical concern of this research design was

providing equal access to the opportunities of the
experimental intervention.

This was controlled by

duplicating the "Living with HIV" program for the control
group and their guests after the three month chart review.
Unexpectedly, the choice of instruments and the individual
response to them also served as a vehicle for change during
the testing period.
Another potential bias was in mortality that resulted
in the loss of subjects from the comparison groups.

In

large studies attrition occurs and is equally distributed
between the experimental and control groups.

Of concern for

this study is the possibility that the experimental stimulus
may have affected the attrition rate.

The anxiety of

attending the program as expressed verbally by one subject
and behaviorally by another in the experimental group drew
attention to dealing with this problem in this and future
studies.

Adjustments to the sample were made by moving two

experimental subjects who completed pre-and-post test to the
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control group.
The clinical significance and meaning of this can be
seen through Hollon and Flick's (1988) model which supported
the notion that at least three constituencies are interested
in the outcome of treatment.

These three include the

patient, society, and the professionals involved.

The value

in keeping the two subjects in the study as control was the
inclusion of their important responses as well as providing
another opportunity for their exposure to the experimental
intervention.

Secondly, the societal interest came from the

gain in increased coping and healthy life-styles, and
conversely, a decrease in the spread of HIV.

Third, the

value for the professional involved was enhanced by the
patient's continued engagement in the process of change.
In this study another bias or advantage was in the
selection of the instruments that were sufficiently balanced
in content, criterion and construct validity for the
population being studied.

The five scales utilized for

hypotheses testing (the Beck Depression Scale, the Hamilton
Depression Rating Scale, the Hamilton Anxiety Rating Scale,
the Impact of Event Scale and the Multidimensional Health
Locus of Control Scale) all had properties of validity,
sensitivity and reliability for this study.

Hamilton (1976)

recognized that patients have many reasons for minimizing
their symptoms or emphasizing them.

This view was the

impetus for the use of both self-report and clinically rated
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scales.

It also represented this researcher's bias in

exposing this population to opportunities to openly assess,
and express, the level of impact their seropositive status
may have on their functioning.
The IES and the HLOC had added face validity by
inserting HIV as the event in question.

These scales were

given after the anxiety and depression scales.

This order

of use might have achieved a different response if the IES
was given as the first self-report with its attention to the
impact of HIV, followed by the other scales with the HLOC as
the end point.

EXTERNAL VALIDITY ISSUES
The efficacy of the independent variable for this study
has been established.

Its application to practice, however,

raises questions about generalization.

As Campbell and

Stanley (1963) succinctly describe the problem:
Whereas the problems of internal validity are solvable
within the limits of the logic of probability
statistics, the problems of external validity are not
logically solvable in any neat, conclusive way.
Generalization always turns out to involve
extrapolation into a realm not represented in one's
sample (p. 17).
One major threat to external validity is the possibility
that experiencing the pretest can alter the subjects'
response to the independent variable, "Living with HIV."
The subjective responses at the posttest supports the
influence of the pretesting on two subjects whose reactions

129
lead to self-adjustments in coping with stress.

From this

example one could extrapolate influence on the other
experimental and control subjects.
Campbell and Stanley (1963) felt the effects of the
pretest as it restricts external validity will be governed
by the extent of repeated measures characteristic of the
population which one wants to generalize.

HIV-infected

individuals are exposed to numerous research studies and
clinical trials that cover medical intervention, quality of
life, coping, and prevention.

Continuous research serves to

inform the scientific community in their efforts at primary
and secondary interventions.

Therefore, generalization of

this study's findings to practice with other stage HIVaffected individuals is possible.

A duplication of the

pretest effects could mean those individuals unable to
attend all the sessions had accrued some properties for
self-adjustment through participation in the pretest alone.
Another threat to external validity is the concern that
those studied are indeed "representative" of other
populations.

Monette, Sullivan and Dejong (1986) caution

that volunteers for studies tend to differ from the general
population as they are better educated, come from a higher
social class and are more sociable.

The demographics in

this study sample appear to support that view as they were
highly educated, with medium to high incomes and volunteered
to participate.

There remains the possibility that the
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effects of validity demonstrated hold only for the unique
population that the experimental and control groups were
jointly selected from.

However, the core issue for people

infected with HIV is in learning how to survive with this
disease.

The study model was structured to allow for

adaptation of its strategies to fit the focus needs of other
HIV-affected populations, thus supporting generalization.
Other methodological implications to the
generalizability of this study is in the interactions of the
setting on the effectiveness of the intervention.

Again, a

caution from Campbell and Stanley (1963) on the
characteristics of the setting that could support the
experimental intervention in ways not replicated in other
settings.

The program goals were designed to support a

response to the changing medical management of HIV.
Therefore, the main focus was on empowerment of individuals
toward the ability to negotiate and form partnerships with
their health care team.

The ability to create a cognitive

reframing of their health concerns within the same setting,
and with some of the same medical staff where the subjects
receive their primary care provided a unique opportunity.
Obtaining similar results is more likely to occur in a
medical setting than in a nonmedical community based
setting.
Achieving the desired balance between internal and
external validity is important to experimental research, but
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not always possible as this study suggests in one single
study.

As Campbell and Stanley (cited in Monette et al.,

1986) suggest "in the last analysis, external validity .
is a matter of replication''

(p. 244).

The literature review

provided guidance in the development of this research model.
Perry et al.

(1991) felt "the ability to use our research

findings to accurately generalize about all subjects will
only be assured after similar prospective studies are
conducted elsewhere in other populations"

(p. 147).

Successful replication of the research results across time
as well as settings will increase confidence in the
importance of this research design and its findings.
Finally, the analysis of the findings focused on change
scores as an assessment of treatment effect.

The most

widely used test is the t test both within the group and
between the group (Campbell & Stanley, 1963) and proved most
appropriate for this study.

All data except the Medical Log

Review had preintervention controls with the ANCOVA's
procedure.

This study proved that the reliability of change

scores is a necessary, but not sufficient condition for
"clinical significance".
It is important to keep in mind that this was a small
sample study (N=l9).

Of course, it is always easier to

obtain a statistically significant result with larger
samples than with smaller ones.

In discussing the lack of

statistically significant findings in the Concord Study the
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researchers' explanation is worth repeating here.

They felt

"with a disease as devastating as AIDS, a chance of even a
5% reduction in progression may be attractive to an
HIV-infected individual"

(p. 867).

Given the uncertainty of

an illness which will wax and wane over many years, changes,
even small ones, are a window of opportunity for increased
quality of life.

IMPLICATIONS FOR SOCIAL WORK PRACTICE

This study has practice implications for clinical
social workers, and in particular, for those working in
medical settings.

With the new perspective on the medical

treatment decisions for HIV comes the recognition of a
change from a biomedical model of AIDS to a biopsychosocial
model, an approach already inherent in social work practice
with the "person-in-situation-person-in environment"
perspective.

Social Workers in AIDS care in the beginning

of this illness described their role more as that of
"witness" or "mirrors" to HIV-infected individual's struggle
and personal evolution (Ryan, 1989) .

This

countertransf erence to the overwhelming feelings of
hopelessness and helplessness needs a cognitive reframing.
The task of working with HIV-affected people is
overwhelming, but not unfamiliar to the social work field of
practice.

The study stress-inoculation model, a model of
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preparation is truly bidirectional in its application.

A

goal of this study was to proactively assist patients in the
pre-AIDS stage of their disease with cognitive-behavioral
skills for coping and survival for the present and future.
The complexity and dynamics of this disease challenges
social workers schooled in the biopsychosocial model as
agents and advocates of change.

The social worker Code of

Ethics mandates that social workers be leaders in seeking
solutions to the complex problems that HIV infection and
disease present to individuals and society.
The process of empowering the experimental group as
consumers of health care services was positively correlated
with their medical compliance.

The intervention "Living

with HIV" served as a transactional model between the
patient, their health care team, and the community.

The

professionals participating in the program reported feelings
of "helpfulness'' in providing strategies for participants to
cope and live with HIV.

These shared feelings define the

stress inoculation model of preparation as bidirectional in
its application between those living with HIV, and those
providing their care.
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RECOMMENDATIONS

This model of intervention was developed from clinical
practice with a predominately homosexual population.

The

face of AIDS is changing and bringing more complexity with
the growing number of infected women and children, as well
as dual and triple diagnosed individuals.

Group

interventions will need to be structured to meet the
particular stressful needs of those targeted populations
(Janis, 1983).

This study provides some guidance for future

efforts along with some recommended changes.
First, the study responses were significantly different

for those diagnosed less than a year and those for a longer
period of time.

The criteria for this study attempted to

combine those subjects in the earlier stages of HIV as
defined by the clinical stages, with the new guidelines for
medical management in the earlier stages of the disease, to
patients new to the clinic within the past six months.
Understanding that people enter the medical system at
different points along the HIV continuum, this created a
dichotomy in time since diagnosis and time in adjustment.
It is suggested for future studies that more careful
attention be given to the selection of subjects in terms of
length of diagnosis, and the stage of their disease.
Second, the use of anti-depressant medications should

be considered as it would affect data results.

Inclusion or

135

exclusion of these subjects must be based on the goals and
intent of the study.

Third, the order of the use of scales

might produce a different response if the scale measuring
the impact of the HIV illness begins the assessments.

This

researcher encourages the replication of the research design
that includes pretesting.

Results have shown that they too

serve as interventions for change, motivating cognitive
ref raming to those unable to unwilling to be exposed to the
intervention.
Fourth, the order of the program might produce a

different result.

The issue of termination needs attention,

but having the last session focus on handling feelings may
or may not have influenced the absence of two participants.
Fifth, the program needs to be extended through

identification of additional adaptive characteristics.
Sixth, finally the need for participants to talk about their

feelings requires more than a half-session of time; a full
session on this topic is recommended, along with a follow-up
session for behavioral interventions giving more time and
attention to self-talk, imagery and relaxation techniques.
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CONCLUSION

The findings from this study are encouraging.
psychoeducational program,

The

''Living with HIV" proved to be

effective in producing awareness and change within the
experimental versus the control group for this sample
population.

The national trend for infection rates for HIV

continues to grow, and with it, increased complications that
challenge social workers to provide new and more creative
modalities for effective coping.

The medical setting is the

core to the linkage of care for HIV-infected individuals,
and the medical social worker is their advocate in the
systems of care.

Intrinsic in all empirical research

efforts with this population is the need for patient
empowerment for coping and survival while living with HIV.

It proves vital in the medical setting where the
uncertainty, unpredictability, and complexity of this
disease demands a partnership in medical decision-making.

APPENDIX A
RECRUITMENT DOCUMENTS
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RESEARCH STUDY
"LIVING WITH HIV"
THIS RESEARCH STUDY WILL EXAMINE THE EFFECTIVENESS OF A
COMPREHENSIVE EDUCATIONAL PROGRAM IN REDUCING THE EMOTIONAL
DISTRESS OF BEING HIV-INFECTED IN THE PRE-AIDS STAGE OF THE
DISEASE.
THIS 6 WEEK PROGRAM WILL MEET ONCE A WEEK FOR 90 MINUTES PER
SESSION AND BE FACILITATED BY THE CLINIC SOCIAL WORKERS AND
INCLUDE AN INFECTIOUS DISEASE PHYSICIAN, A PSYCHIATRIST,
CLINICAL NURSE SPECIALIST, DIETITICAN, LAWYER AND A SOCIAL
SECURITY ADVISOR. THE PROGRAM INTERVENTIONS DESIGNED FROM THE
LITERATURE REVIEW ON THE IMPACT OF HIV IN THE EARLIER STAGE OF
DISEASE ARE INTENDED TO:
1) PROMOTE MEDICAL EDUCATION, MEDICAL COMPLIANCE, AND RISK
REDUCTION BEHAVIORS.
2) ENABLE PATIENTS TO EXERCISE MORE CONTROL OVER THEIR HEALTH
BY BECOMING INFORMED CONSUMERS OF HEALTH CARE SERVICES, AND
FORMING PARTNERSHIPS WITH THEIR HEALTH CARE TEAM.
3) PROVIDE SKILL ENHANCING TECHNIQUES FOR ADAPTIVE COPING AND
REDUCTION OF EMOTIONAL DISTRESS.
THERE IS NO CHARGE TO ATTEND THIS PROGRAM.
CRITERIA: PATIENTS WHO ARE NEW TO THE COMPREHENSIVE AIDS CENTER
WITHIN THE PAST SIX MONTHS WITH A CD4 COUNT OF GREATER THAN 200
WITH NO RECORD OF OPPORTUNISTIC INFECTIONS THAT DEFINE
PROGRESSION TO AIDS CONFIRMED BY THEIR MEDICAL RECORDS.
PATIENTS WITH A HISTORY OF DRUG ABUSE MUST BE IN RECOVERY FOR
AT LEAST THREE YEARS.
SCHEDULE: THE STUDY IS SCHEDULED TO BEGIN ON THURSDAY, JANUARY
13th FROM 6:00 -7:30 PM. THIS RANDOMIZED STUDY MEANS HALF OF
THE PARTICIPANTS WILL BE INVITED TO ATTEND THIS PROGRAM AND THE
OTHERS WILL BE ASKED TO ATTEND OUR NEXT SCHEDULED PROGRAM IN
APRIL. AN HOUR INTERVIEW BEFORE AND AFTER THIS PROGRAM IS
REQUESTED. THEREFORE, PLEASE CONTACT ME UPON RECEIPT OF THIS
LETTER TO SCHEDULE AN APPOINTMENT AT YOUR CONVENIENCE. PLEASE
CALL NANCY CADDICK AT (312) 908-5116 BETWEEN 9:00 AM AND 5:00
PM, OR PAGE ME THROUGH (312) 908-2060. THANK YOU FOR YOUR
CONSIDERATION.
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EFFECTIVENESS OF A COMPREHENSIVE EDUCATIONAL PROGRAM IN
REDUCING EMOTIONAL DISTRESS FOR HIV-INFECTED PEOPLE IN THE
PRE-AIDS STAGE OF DISEASE.
INFORMED CONSENT

INTRODUCTION
This research study will examine the effectiveness of this
educational program in reducing the emotional distress of being
HIV-infected for patients new to the Comprehensive AIDS Center
within the last six months, and whose CD4 count is greater than
200 with no record of opportunistic infections that define
AIDS.
Research has shown that patients in the earlier stages of the
HIV disease experience significantly higher levels of
depression, mood disturbance and anxiety than do those patients
with AIDS. Thus, the need exists for a comprehensive approach
towards adaptive coping by providing consumer education on
medical care, mental health care, nutrition, and legal and
insurance advice.
PURPOSE
The purpose of this study is to examine the effectiveness of
the program "Living with HIV" as an intervention to reduce
depression and anxiety while at the same time increasing a
sense of control and preparation through consumer education and
stress reducing techniques. The program interventions designed
from the literature review on the impact of HIV in the earlier
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stage of the disease are intended to:
1) promote medical education, medical compliance, and risk
reduction behaviors.

2) enable patients to exercise more control over their
health by becoming informed consumers of health care
services, and forming partnerships with their Health Care
Team.
3) provide skill enhancing techniques for adaptive coping

and reduction of emotional distress.
PROCEDURES
Should I be eligible to participate in this study, and I agree,
I will be interviewed and asked demographic information such as
age, sex, ethnicity, marital/partner status, education,
employment status, HIV risk factor and CD4 count. I will also
be asked to complete 5 psychological assessment scales that
will take approximately 55 minutes. Next I will be randomized
(assigned by chance) to either:
1. attend a six week, 90 minute per week session of the
"Living with HIV" program, and I may bring two guests.
Information about the program schedule and location will be
made available to me.
2. offered current clinic services and be invited to attend
the next program anticipated early in 1994.
Upon completion of the six week program, I will be asked to
once again complete 5 psychological assessment scales that will
take approximately 55 minutes.
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BENEFITS

The benefits to me for my participation in this study are to
receive from my Health Care Team a comprehensive educational
program to aid me and my significant others in understanding
and living with the HIV disease.
By participating in this study I will be assisting in
determining the importance of this model as a continuing
intervention for patients in the pre-AIDS stage of the disease
at the Comprehensive AIDS Center.
RISKS

The only slight concern involves the possibility of an
emotional reaction to the psychological assessment scales or
with the materials presented at the program. Should this occur
in any slight way, I am encouraged to contact one of the clinic
social workers. If these feelings persist, I am free to
withdraw from the study at any time, and that this would not
affect my relationship with the clinic or any member of the
medical staff.
ALTERNATIVE PROCEDURES

New Comprehensive AIDS Center patients receive a clinic packet
describing the various services and staff members. Should I
desire additional information or resources I can request an
appointment with one of the clinic social workers.
COSTS

There are no related costs to participating in this study.
CONFIDENTIALITY

My research records will be kept confidential and in a locked

144

file.

I will be identified by a number code on the demographic

and psychological assessment scales listed on a master list to
be destroyed at the completion of the study. Only first names
will be used during the program. None of the study information
will be included in my medical records. I will not be
personally identified in any publication about this study.
SUBJECTS RIGHTS
Participation in this study is voluntary and refusal to
participate will involve no penalty or loss of benefits. As
stated above, subjects may withdraw at any time without penalty
or loss of benefits, and that withdrawal will not affect their
relationships with the clinic or any member of the medical
staff. Any additional questions or concerns regarding this
study should be directed to Nancy Caddick at (312) 908-5116
between the hours of 9:00am to S:OOpm, Monday through Friday.
CONSENT
I agree to participate in the research study outlined above and
I will receive a copy of the consent form.

Signature of Subject

Date

Signature of Witness

Date

APPENDIX C
PROGRAM DOCUMENTS
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January 6, 1994

Dear Study Participants;
The "Living with HIV" research study is scheduled to
begin next Thursday, January 13th, and for the next five
consecutive Thursdays ending on February 17th. The program
will run from 6:30 to 8:00 pm and will meet in the Conference
Room on the eighth floor of the Passavant Pavilion at 303 E.
Superior Street. The agenda for the program is enclosed and
is designed to address the medical, psychosocial and
psychological issues of being HIV-infected. Several
psychoeducational strategies have been created to help you
cope and live daily with HIV, therefore, we hope you will
arrange your calendar to allow attendance at each session.
We would like to know in advance if you will be bringing
guests ( up to two) and if you will be driving in order to
arrange for parking at the NMH parking lot on Erie and
Mcclurg Streets (across from CBS). Also, we plan to have
light refreshments, and for confidentiality, we will use only
first names during the program.
Please leave a message for me at (312) 908-5116 regarding
your ability to attend as well as parking needs and if you
will bring guests. Looking forward to seeing you on Thursday,
January 13th.
Nancy Caddick
Clinical Social Worker
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STRATEGIES FOR LIVING DAILY WITH HIV

l. AWARENESS OF THE HIV CLINIC'S OPERATION AND STRUCTURE
CREATES ACCESS TO SERVICES AND INFORMATION TO ASSIST
IN YOUR HEALTH CARE NEEDS.

2. DEVELOPING A PARTNERSHIP IN HEALTH CARE TREATMENT
DECISIONS WITH YOUR PHYSICIAN AND HEALTH CARE TEAM.

3. PREPARE FOR YOUR CLINIC APPOINTMENTS WITH QUESTIONS
ANO/OR CONCERNS. BRING A LIST OF YOUR MEDICATIONS.

4. ATTENTION TO YOUR NUTRITIONAL HABITS IN FOOD CHOICE,
PREPARATION AND SUPPLEMENTS.

5. UNDERSTANDING YOUR RIGHTS TO LEGAL PROTECTION UNDER
THE LAW, AND ELIGIBILITY TO FEDERAL AND STATE
ENTITLEMENTS AND PROGRAMS AS NEEDED.

6. BECOME A CONSUMER OF HEALTH CARE SERVICES -KNOW YOUR
POLICY AND ITS BENEFITS - KNOW WHO DOES WHAT, WHEN
ANO HOW.

7. PAY ATTENTION TO YOUR MENTAL HEALTH NEEDS ANO SEEK
HELP THROUGH INDIVIDUAL OR GROUP THERAPEUTIC SUPPORT.
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LIVING WITH HIV
PROGRAM EVALUATION
We would appreciate your comments on this program to help us
prepare for future ones. Please Place an X through the word
that best describes your feelings.
SESSION I. Introduction to the Program and HIV Clinic:
1. Did you feel you received enough information to organize
your time and prepare you for this program?
VERY MUCH

ENOUGH

NOT ENOUGH

2. Did you feel the information on the HIV Clinic provided
you with a working understanding of how it operates that will
be helpful to you?
VERY MUCH

ENOUGH

NOT ENOUGH
SPEAKERS=~~~~~~~~~~~~~

COMMENTS ON MATERIAL AND

SESSION II. Medical Management of HIV Disease:
1. Did you find this presentation helpful in understanding
the HIV disease and treatment options?
VERY MUCH

ENOUGH

NOT ENOUGH

2. Were the suggestions for strategies for a healthy life
style along with ways to work with your physician helpful?
VERY MUCH

ENOUGH

COMMMENTS ON MATERIAL AND

NOT ENOUGH
SPEAKER~~~~~~~~~~~

SESSION III. Nutrition
1. Did you find the presentation on nutrition provided the
information you needed to assess your eating habits and make
appropriate changes?
VERY MUCH

ENOUGH

COMMENTS ON MATERIAL AND

NOT ENOUGH
SPEAKER~~~~~~~~~~~~
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SESSION IV. Lesal Issues/Social Security
1. Did you find the presentation on the legal issues on
being HIV-infected helpful in understanding your rights?
VERY MUCH

ENOUGH

NOT ENOUGH

2. Was the information on Social Security helpful for you at
this time?
VERY MUCH

ENOUGH

COMMENTS ON MATERIAL AND

NOT ENOUGH
SPEAKERS~~~~~~~~~~~~

SESSION V. Resources for Empowerment
1.Did you find this presentation on insurance issues helpful
in understanding your choices in health care, as well as ways
to plan for your health care needs?
VERY MUCH

ENOUGH

COMMENTS ON MATERIAL AND

NOT ENOUGH
SPEAKER~~~~~~~~~~~~~-

SESSION VI. Handling Feelings/Stress Management
1. Did you find this session helpful in discussing the ways
that mood and emotions impact on coping with HIV?
VERY MUCH

ENOUGH

NOT ENOUGH

2. Do you feel that using the relaxation techniques and
self-statements will be helpful for you to cope with your
feelings?
VERY MUCH

ENOUGH

COMMENTS ON THE MATERIAL AND

NOT ENOUGH
SPEAKER~~~~~~~~~~~

WHAT IS YOUR OVERALL FEELINGS ABOUT THIS PROGRAM? WHAT DID YOU
FIND HELPFUL, WHAT WASN'T? YOUR COMMENTS ARE GREATLY
APPRECIATED.( you can use the other side if needed)

APPENDIX D
INSTRUMENTS
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DEMOGRAPHICS

CODE NO:

START

DATE:

.s..EX,: M._ _ _ F _ _

AQE: _ __

ETHNICITY: White

African-American

Hispanic

Asian

Other _______________

MARITAL/PARTNER:

Single

Married/Live-in-Partner

Separated

EDUCATION: <HS

HS

<C

EMPLOYMENT:

Full-Time

RISK FACTOR:

Gay

IVDU

ga: _ __

DATE OF DX:MONTH/YEAR

C

Divorced

G

Widowed

Highest Level _ ___

Part-Time

Transfusion

Unemployed

Hemophiliac

Partner
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UNIVERSITY

of PE.YNSYLVA.VIA

PHIL\DELPHI.\ 19UJ-!-:32-!6

October 1, 1993

Center for Cugnitir:e Theraplj

Room 73.+. The Sc1em:e CL·lltl'r
'](;(Ml \larket Strl'c•t
Phil .... P. \ l9 l0.J-2fi.J.'i
215-.'>98-.J l 00
F:c" 2!5-·'>9.'i-l~fi5

Nancy Caddick
680 N. Lake Shore Dr.
Chicago, Il 60611

Dear

~s.

Please reply to:

Caddick

On behalf of Aaron T. Beck, M.D., I am responding to your
recent inquiry regarding our research scales.
You have Dr. Beck's permission to use and reproduce the
scale(s) checked below only for the designated research project
that you described in your letter. There is no charge for this
permission.
However, in exchange for this permission, please provide Dr.
Beck with a complimentary copy of any reports, preprints, or
publications you prepare in which our materials are used. These
will be catalogued in our central library to serve as a resource
for} other researchers and clinicians.
_../_ B
Beck Depression Inventory (BO!)

Weekl

eek Anxiety Inventory (BAI)
_

Hopelessness Scale (HS)
Suicide Intent Scale

(PRTS)
_Anxiety Checklist (ACL)
(CCL)

fs't. 'S'S'

_

Beck Self-Concept (BSCT)
Pnfunctional Attitude Scale (DAS)

If you have any further questions, feel free to contact me.
Sincerely,

t'

d. ,;__,;_,,,,
Karen A. Quinn
Assistant to Aaron T. Beck, M.D.
NOTE:

Permission for inclusion of the BDI, BAI, BS, SSI, and
BSCT in any publication must be obtained from The
Psychological Corporation; telephone t: 1-800-228-0752.
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_ S·::.:""e:

Q10 Have you a:::mpted to -or do you
int:r.d to - kill yoursa!f?

-:::~;:;!y

so

Q'12 Do ycu fe~1 a~xicl!s cr~a::se?

.03

Q4

Is i-r taki:-:~ [cnge; to ~et aff to s!eep?
-

S..:::"! : " . ·-

-

Sc::-! : if s,::-:"":eti:-:-:!s

Do you sleep fi-:7:.:ily - of:en
a't.raker.ir.g.,

= Sc::-=
Sc:::-? ·J

S:.::.~a

. .: .:

::::~

Sc:c: : : ; ::

Qi3 Do you s;.;:'"'e; from ar:y ;::hys;caf

s·1mt:=:ci7.s?

If . . . c
i if sc.-:":a~!;.:.es

Q5

Do you waken earlier than usual
anc then find yourself unable to get
back to sleep?

014 Are ye!.! -.·:: i:-fed tha! you mi;ht have a
ser:ous ii!.-: ass such as cancer or VD?

Sc::r= IJ if r:::
Sc::r: i if sc~ati~es
Sc::r= 2 if ai•.vays

Q6

Have you lest imerest in your work
or hobbies?
Sc::r? a if r.ct at all
Sc:ra 1 if 3 lit:le
Sc::re 2 if ~cceraceiy so
Sc:ra 3 if a loc
Sc::re ! if ext:!mefy so

Q15 Have you lest interest in sex?

=
=

Sc::r'? •J :f :-:c
Sc::ra 'i if sc~~timas
Sc::ra Z :f a!ways

Q 16 Have ycr...:. lost weight recently -

exc!ud-

ing that cr...:.e to dieting?

07 ls life pointless?

=
=

Sc:r!

a if 110

Sc::ra 1 if yes
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·=

·=
Q9

Seer!
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Scor~ t ii yes

_
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."':":CC!rata!y so

0 ::
1 if
: if
Sc::ra J :f
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! ~ot

!xt:-!me!y so

Q17 Are you a"'C your worst early in the daybut improve as the day goes on?

Have you made plans to kill yourself?
-

."':c:

Seer!

Sc~r:e

Have you thought of ending it all?

ac all

Sc~re

-

St.::Jr~

,J 1f

s..:~r!

i ;: s.::":"":e~irnes

Sc::r!

~

HA;';;Q

::

.~~
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Hamilton Anxiety Rating Scale

lnsrr:zc::ons:

Th:s chc:ckli'.\! is :o ~H;s~ :.ic physician or psyc!'u::tnst :n i..:vaiu::ung e:::::i ;:it:..:::c
c:or.a::ion. Ph:::sc :il! ::: !he appropn:w: ~ttng:
.~0.'lf:.

= 0

"'~:i = I

.\IOCE~A TE

An.'1ous mood

= 2

Raring

Item

\Vorr::s. J.r.~~.::o:uon of
~:-::: .,.,.orsL :·:.lrr"ul Jnti-
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J:i

:v

~:.; .;.:;::~ ~f Jn.t:e::·
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F::~~ings

T.::::!-.yc:;::J.. :!:::::rions.
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e~sdy. :::~~ling. fe:!-

:·:.:::::::;
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·1orr:::::-:~.

:i.1~:-::-~:::-crs
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:r.e~:::::

J'.:-::c:..:::·. - : .:. ::::o·,.;,.·ir.g.
·..i-tr.c. ;,:.:.:~.::::.~ pa1:-..
·,:.:.-:-:::-:; ::::-:::.::::-:s. Jbdo:..::-:::-:~:::.t.

Iac$!:::=i°; ::· =~·.:.·~~s. !os:s
0 f ·;.. !: ;:-:.. :: :".l::~l~i.C:".
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unste:iav vo:c:. inc:c:ascd · :r:us.::.:.iu tone

symptoms

at inti!'rriew
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:e:-:d'!::::: :o :·.:.e:C. giCdir.ess. ::::s:::-: :::.2dac::=.
ratstng ~;· :;,:::

F:tge~:~g:. :-:s:'.::ss~:s.s
~ac•ng. ::-~~~:

or
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50.

:~c~:-:~:::irmos
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IMPACT OF EVENT SCALE
( IES)
Being HIV-infected is a stressful life event. Below are some
statements made by people about this stressful live event. Please
read each item and decide how frequently each item was true for you
during the last seven (7) days in regards to being HIV-infected. If
the item did not occur in the past seven days, choose the "Not at
all" option. Circle the number that best describes each item. Please
complete each item.
Not at all

Rarely

Sometimes

Often

1.

I thought about it when I
didn't mean to.

1

2

3

4

2.

I avoided letting myself get
upset when I thought about it
or was reminded of it.

1

2

3

4

3.

I tried to remove it from memory.

1

2

3

4

4.

I had trouble falling asleep or
1
staying asleep, because of pictures
or thoughts about it that came into
my mind.

2

3

4

5.

I had waves of strong feelings
about it.

1

2

3

4

6.

I had dreams about it.

1

2

3

4

7.

I

1

2

3

4

8.

I felt as if it hadn't happened or
wasn't real.

1

2

3

4

9.

I tried not to talk about it.

1

2

3

4

10. Pictures about it popped into

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

stayed away from reminders of it.

my mind.
11. Other things kept making me think

about it.
was aware that I still had a lot
of feelings about it, but I didn't
deal with them.

12. I

13. I

tried not to think about it.

14. Any reminder brought back feelings

about it.
15. My feelings about it were kind of

numb.
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MULTIDIMENSIONAL HEALTH LOCUS OF CONTROL SCALE
(HLOC)

Form C
INSTRUCTIONS: Each item below is a belief statement about HIV with which
you may agree or disagree. Beside each statement is a scale which ranges
from strongly disagree (1) to strongly agree (6). For each item we would
like you to circle the mumber that represents the extent to which you
disagree or agree with the statement. The more strongly you agree with a
statement, then the higher will be the number you circle. The more
strongly you disagree with a statement, then the lower will be the
number you circle. Please make sure that you answer every item and that
you circle only one number per item. This is a measure of your personal
beliefs; obviously, there are no right or wrong answers.
l=STRONGLY DISAGREE
2=MODERATELY DISAGREE
3=SLIGHTLY DISAGREE

4=SLIGHTLY AGREE
5=MODERATELY AGREE
6=STRONGLY AGREE

D A

SD

MD

1. If my HIV worsens, it is my own behavior
which determines how soon I feel better
again.

1

2

3

2. If I see my doctor regularly, I am less
likely to have problems with my HIV.

1

2

3

4

5

6

3. Most things that affect my HIV happen to
me by chance.

1

2

3

4

5

6

4. Whenever my HIV worsens, I should consult
a medically trained professional.

1

2

3

4

5

6

5. I am directly responsible for my HIV getting
better or worse.

1

2

3

4

5

6

6. Other people play a big role in whether my
HIV improves, stays the same, or gets worse.

1

2

3

4

5

6

7. Whatever goes wrong with my HIV is my own
fault.

1

2

3

4

5

6

8. Luck plays a big part in determining how my
HIV improves.

1

2

3

4

5

6

4

MA

SA

5

6
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!=STRONGLY DISAGREE
2=MODERATELY DISAGREE
3=SLIGHTLY DISAGREE

4=SLIGHTLY AGREE
S=MODERATELY AGREE
6=STRONGLY AGREE

9. Whatever improvement occurs with my HIV
is largely a matter of good fortune.

SD

MD

D

A

MA

SA

1

2

3

4

5

6

10. The main thing which affects my HIV is what
I myself do.

1

2

3

4

5

6

11. If my HIV worsens, it's a matter of fate.

1

2

3

4

5

6

12. Following doctor's orders to the letter is
the best way to keep my HIV from getting
any worse.

1

2

3

4

5

6

13. If my HIV takes a turn for the worse, it is
because I have not been taking proper care
of myself.

1

2

3

4

5

6

14. The type of help I receive from other people
determines how soon my HIV improves.

1

2

3

4

5

6

15. In order for my HIV to improve, it is up to
other people to see that the right things
happen.

1

2

3

4

5

6

16. I deserve the credit when my HIV improves
and the blame when it gets worse.

1

2

3

4

5

6

17. If I am lucky, my HIV will get better.

1

2

3

4

5

6

18. As to my HIV, what will be will be.

1

2

3

4

5

6
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MEDICAL REVIEW LOG

Date

\!ONTHS

COMPLETED

FIRST

Reviewed~~~~~~~-

SECOND

THIRD

APPOI~T~E~TS

MEDICATIONS
Oral
Intr,.venous
Aerosol

SPECIALTY REFERRAL

Guidelines: Kept appointments,

took all medications agreed upon

and followed through on speciality referrals
Key: Y (YES), N (NO), NA (Not Appropriate)

APPENDIX E
REVIEW BOARD APPROVALS
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NORTHWESTERN
UNIVERSITY

Office for the Pror=ion cf Research Subject!
!mlitmiaul Rmew Boon!
Animal ~ .t: Use Commiuee

Ncverr:!:::e:::- 1, 1993

Nancv Caddick,

LCS~

Comp=e~ensive AIDS Cente:::-

Passavant, 826
Chicago Campus
Re:

Effectiveness of a Biopsychosocial Educational Program.
in Reducing E:motional Distress Using the Stress Inoculation
Model for HIV-Infected People in the Pre-AIDS Stage of
Disease

Dea:::- Ms. Caddick:
At its October 29, 1993 meeting, the Insti~uticnal Review Board
conside:::-ed and approved* your submission referenced above for a
one-yea:::- period ending October 31, 1994. This approval applies
to the use of human subjects only, and dces not cons~itute
scientific approval of the project. Scientific approval must be
obtained from the NMH or RIC Research Committee befc:::-e the
project may be initiated.
IRB approval is given with the understanding that nc changes may
be made in the procedures to be followed nor the consen~ form(s)
to be used until such modifications have been submitted to the
IRB fa:::- review and have been given approval.
Any unanticipated problems involving risk to human subjects and
any serious adverse effects must be reported promptly to the IRB.
One month prior to the expiration of this approval, you will
receive notification of the need for updated information to be
used for the project's periodic review.
Information concerning
implementation and results to date will be required at that time.

c~:;/f
/iZiw~
~:ne
G. IRichmond

Manager

*Please delete the first sentence in the Risk section.
IRB when this is done.
cc:

John Phair, M.D.
Robert Murphy, M.D.
Baiba Berzins
Tamara Norman

313 !aat Chlcaao Au••• Chlcaao, llllnol1 "'11-Jttl 311°513°'331 I P'AX 312-513-1555
Ornce ot the Vice Pruldeat tor Ruearda a•d Graduate Studies

Copy the
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RESEARCH COMMIITEE
Norr/Jwr:stenz Nemon3.I Hospiu.I

Vett:raDS ALQUs

Office of Researdl

Lakeside :'vfed.ic:U C:nter

215 E. ChiC1go Ave. #913
(312) 908 - ::670 OFFICE
(312) 908 - 0051 FAX

RESEARCH OFFICE
E. 0 ntario. Rm. 10 l
(312) 943~. fat. 511
.lOQ

December 8, 1993

Nancy Caddick, LCSW
Comprehensive AIDS Center
Passavant, Room 826
Chicago Campus

RB:

Research study #93-11-14
Effectiveness of a Biopsychosocial Educational Progr~m in
Reducing Emotional Distress Using the Stress Inoculation
Model for HIV-Infected People in the Pre-AIDS Stage of
Disease

Dear Ms. Caddick:
The above referenced project received scientific and
administrative APPROV1J. from the NMH Research Committee and
Office of Research on Nove1Dber 17. 1993.
The committee ~ishes
you success in your endeavor to accomplish this project.
You may commence with this project provided that APPRDV1.L
has been received from the Institutional Review Board for the
use of human subjects, and administrative issues are resolved
(i.e. executed contract containing an indemnification clause,
account established for ancillaries services, etc).
If you need any additional assistance regarding this
project, please do not hesitate to contact us.
Thank you.
Sincerely,
•tJ 1 /,..I
f ~-1~/c::.-.

<i

Pe~r

.. -

J. Kahrilas, M.D.

Chairman
NMH Research

Commit~ee

~JJ.*'-•-41
Bonnie Aguda
Director of Research
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INSTITUTIONAL REVIEW BOARD
RESEARCH SERVICES OFFICE
LOYOLA UNIVERSITY OF CHICAGO
6525 NORTH SHERIDAN ROAD
CHICAGO IL 60626
Tel:

{312) 508-2471

Matthew Creighton, SJ, Chair
October 13, 1993

Investicator:
Home Address:

Nancy S. Caddick
680 North Lake Shore Drive
#1311L
Chicago, Illinois 60611
Home Teleohone:
951-7348
[Area Code: 312]

I Please check the above information fer accuracy i
I

and call in any corrections to 508-2471

;

Dear Colleague,
Thank you for submitting the following research
project for review by the Institutional ?.eview Board fer
the Protection of Human Subjects:
Project Title:

Effectiveness of a Bio9sychological
Education Program in Reducing Emotional
Distress Using the Stress Inoculation

After careful examination of the materials you submitted,
we have approved this project as described for a period of
one year from the date of this letter.
Approximately eleven months from today, you will
receive from the I?.B a letter which will ask whether you
wish to apply for renewal of IRB approval of your project.
You will be asked whether there have been any changes in
the nature of the involvement of human subjects in your
project since it was first approved, and whether you
foresee any such changes in the near future.
If your
responses to these questions are timely and sufficiently
explicit, the IRB will at that time renew your approval
for a further twelve-month period.
If you do not return
that form by October 13, 1994, however, your approval will
automatically lapse.
This review procedure, administered by the IRB itself,
in no way absolves you personally from your obligation to
inform the IRB in writing immediately if you.propose to
make any changes in aspects of your work that involve the
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participation of human subjects. The sole exception to
this requirement is in the case of a decision not to
pursue the project--that is, not to use the research
instruments, procedu=es or populations originally
approved. Researchers are respectfully reminded that the
University's willingness to support or to defer.d its
employees in legal cases that may arise from their use of
human subjects is dependent upon those employees'
conformity with University policies regarding IRB approval
for their work.
Should you have any questions rega=ding this letter or
the procedures of the IRB in general, I invite you to
contact me at the address or the telephone numbe= shown en
the letterhead.
If your question has directly to do with
the project we have just approved for you, please guote
file number 1080.
With best wishes fer your work,

Tn~.u» ~~(j-J
Matthew Creighton, SJ

cc: Graduate School/WTC
inter-office memrar.cum S. Condon

APPENDIX F
PSYCHOLOGICAL ASSESSMENT TABLES
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ANALYSIS OF COVARIANCE TABLE

SCALE
(POSTTEST)
BDI

EXPERIMENTAL-CONTROL
(Differences)

STD E
(Differences)

P-Value

0.819

0.28

0.785

-2.821

-1.08

0.295

HAS

1. 598

0.62

0.543

IES-I

1.719

1. 20

0.246

IES-A

4.853

2.65

0.017

HLOC-I

-0.784

-0.43

0.673

HLOC-D

0.507

0.29

0.774

HLOC-0

-1.467

-1.24

0.233

HAMD
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POOLED T-TEST TABLE
(POST-PRE)

SCALE

M

EXPERIMENTAL
p
STDE

M

CONTROL
STDE

p

BDI

-1.125

2.490

0.643

0.363

1.912

0.636

HAMD

-4.000

1.742

0.165

-0.363

1.805

0.178

HAS

-0.375

2.329

0.847

-1.000

2.174

0.849

IES-I

1.125

1. 630

0.905

1.363

1.114

0.901

IES-A

2.750

1.810

0.406

0.727

1.526

0.403

HLOC-I

-2.750

1.485

0.408

-1.181

1.085

0.394

HLOC-D

-0.125

1.940

0.980

-0.181

1.060

0.978

HLOC-0

-1.375

1.335

0.256

0.363

0.526

0.194
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